UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 682.

A

ARESU, M; Brage, S; Mindell, J; (2009) Physical fitness in adults. (Health Survey for England (2008). Volume 1 Physical activity and fitness ). The Health and Social care Information Centre: Leeds.

Agarwal, A; Kocjan, G; (2009) FNAC Thyroid Reporting Categories: Value of Using the British Thyroid Association (Thy 1 to Thy 5) Thyroid FNAC Reporting Guidelines. CYTOPATHOLOGY , 20 (2) 133 - 134. 10.1111/j.1365-2303.2008.00625.x.

Ahlskog, JKJ; Schliemann, C; Marlind, J; Qureshi, U; Ammar, A; Pedley, RB; Neri, D; (2009) Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. BRIT J CANCER , 101 (4) 645 - 657. 10.1038/sj.bjc.6605200.

Ahmed, N; Salsman, VS; Yvon, E; Louis, CU; Perlaky, L; Wels, WS; Dishop, MK; ... Gottschalk, S; + view all (2009) Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression. MOLECULAR THERAPY , 17 (10) pp. 1779-1787. 10.1038/mt.2009.133.

Al-Qassab, H; Smith, MA; Irvine, EE; Guillermet-Guibert, J; Claret, M; Choudhury, AI; Selman, C; ... Withers, DJ; + view all (2009) Dominant Role of the p110 beta Isoform of PI3K over p110 alpha in Energy Homeostasis Regulation by POMC and AgRP Neurons. CELL METAB , 10 (5) 343 - 354. 10.1016/j.cmet.2009.09.008. Gold open access

Altvater, B; Landmeier, S; Pscherer, S; Temme, J; Schweer, K; Kailayangiri, S; Campana, D; ... Rossig, C; + view all (2009) 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells. CLINICAL CANCER RESEARCH , 15 (15) pp. 4857-4866. 10.1158/1078-0432.CCR-08-2810.

Amit, I; Garber, M; Chevrier, N; Leite, AP; Donner, Y; Eisenhaure, T; Guttman, M; ... Regev, A; + view all (2009) Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses. Science , 326 (5950) pp. 257-263. 10.1126/science.1179050.

An, S; Henriquez, N; Puls, F; Brandner, S; (2009) Oligodendrogliomas: relation of morphology to 1p/19q genotype. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 11 - 12). BLACKWELL PUBLISHING

Andre, T; Boni, C; Navarro, M; Tabernero, J; Hickish, T; Topham, C; Bonetti, A; ... de Gramont, A; + view all (2009) Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial. JOURNAL OF CLINICAL ONCOLOGY , 27 (19) pp. 3109-3116. 10.1200/JCO.2008.20.6771.

Apostolidou, S; Hadwin, R; Burnell, M; Jones, A; Baff, D; Pyndiah, N; Mould, T; ... Widschwendter, M; + view all (2009) DNA methylation analysis in liquid-based cytology for cervical cancer screening. INT J CANCER , 125 (12) 2995 - 3002. 10.1002/ijc.24745.

Arce, F; Rowe, HM; Chain, B; Lopes, L; Collins, MK; (2009) Lentiviral Vectors Transduce Proliferating Dendritic Cell Precursors Leading to Persistent Antigen Presentation and Immunization. MOL THER , 17 (9) 1643 - 1650. 10.1038/mt.2009.149.

Arkenau, ; (2009) Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer: A Pooled Analysis of Randomized Trials (vol 26, pg 5910, 2008). JOURNAL OF CLINICAL ONCOLOGY , 27 (34) p. 5859. 10.1200/JCO.2009.26.9142.

Arkenau, H; Evans, J; Lokelma, M; Roxburgh, P; Morisson, R; Coffey, M; Gill, G; ... de Bono, J; + view all (2009) A phase I study of the combination of intravenous Reolysin (REO) and gemcitabine (GEM) in patients (pts) with advanced cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Arkenau, H-T; (2009) Gastric cancer in the era of molecularly targeted agents: current drug development strategies. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , 135 (7) pp. 855-866. 10.1007/s00432-009-0583-7.

Arkenau, H-T; Barriuso, J; Olmos, D; Ang, JE; de Bono, J; Judson, I; Kaye, S; (2009) Prospective Validation of a Prognostic Score to Improve Patient Selection for Oncology Phase I Trials. JOURNAL OF CLINICAL ONCOLOGY , 27 (16) pp. 2692-2696. 10.1200/JCO.2008.19.5081.

Arkenau, H-T; Brunetto, AT; Barriuso, J; Olmos, D; Eaton, D; de Bono, J; Judson, I; (2009) Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer. ONCOLOGY , 76 (3) pp. 151-156. 10.1159/000195884.

Arkenau, HT; (2009) Capecitabine/oxaliplatin results in outcome similar to infusional 5 FU/leucovorin/oxaliplatin in MCRC: Results of a meta-analysis. American Journal of Hematology/ Oncology , 8 (5)

Averdam, A; Petersen, B; Beck, S; Reinhardt, R; Walter, L; (2009) A novel system of polymorphic NK cell receptors identified in primates. In: TISSUE ANTIGENS. (pp. 386 - 386). WILEY-BLACKWELL PUBLISHING, INC

Averdam, A; Petersen, B; Rosner, C; Neff, J; Roos, C; Eberle, M; Aujard, F; ... Walter, L; + view all (2009) A Novel System of Polymorphic and Diverse NK Cell Receptors in Primates. PLOS GENET , 5 (10) , Article e1000688. 10.1371/journal.pgen.1000688. Green open access
file

Ayaru, L; Stoeber, K; Webster, GJ; Hatfield, ARW; Wollenschlaeger, A; Williams, G; Pereira, SP; (2009) DIAGNOSIS OF PANCREATICOBILIARY MALIGNANCY BY DETECTION OF MINICHROMOSOME MAINTENANCE PROTEIN 5 IN BILIARY BRUSH CYTOLOGY SPECIMENS. In: GUT. (pp. A25 - A25). B M J PUBLISHING GROUP

B

BBC, NO; (2009) Thalidomide lung cancer 'failure'. UNSPECIFIED

Backdahl, L; Bushell, A; Beck, S; (2009) Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. INT J BIOCHEM CELL B , 41 (1) 176 - 184. 10.1016/j.biocel.2008.08.023.

Backdahl, L; Herberth, M; Wilson, G; Tate, P; Campos, LS; Cortese, R; Eckhardt, F; (2009) Gene body methylation of the dimethylarginine dimethylamino-hydrolase 2 (Ddah2) gene is an epigenetic biomarker for neural stem cell differentiation. EPIGENETICS , 4 (4) 248 - 254.

Backdahl, L; Herberth, M; Wilson, G; Tate, P; Campos, LS; Cortese, R; Eckhardt, F; (2009) Gene body methylation of the dimethylarginine dimethylamino-hydrolase 2 (Ddah2) gene is an epigenetic biomarker for neural stem cell differentiation. Epigenetics , 4 (4) pp. 248-254.

Badie, S; Liao, C; Thanasoula, M; Barber, P; Hill, MA; Tarsounas, M; (2009) RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation. J Cell Biol , 185 (4) pp. 587-600. 10.1083/jcb.200811079.

Bajwa, A; Blunt, N; Vyas, S; Suliman, I; Bridgewater, J; Hochhauser, D; Ledermann, JA; (2009) Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. EJSO , 35 (2) 164 - 167. 10.1016/j.ejso.2008.06.005.

Balasubramaniam, T; Johnson, R; Cwynarski, K; Ackroyd, S; El-Sharkawi, D; Ashcroft, J; McNamara, C; ... Moreton, P; + view all (2009) Treatment outcomes of primary CNS lymphoma with IDARAM chemotherapy regime. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 14 - 14). WILEY-BLACKWELL PUBLISHING, INC

Balbi, KJ; Rocha, EPC; Feil, EJ; (2009) The temporal dynamics of slightly deleterious mutations in Escherichia coli and Shigella spp. Mol Biol Evol , 26 (2) pp. 345-355. 10.1093/molbev/msn252.

Balding, DJ; (2009) Weight-of-Evidence for Forensic DNA Profiles.

Banerjee, L; Mansour, M; Khwaja, A; (2009) Combined blockade of PI3-kinase and mTOR synergizes with gamma-secretase inhibitors to induce a high level of cell death in T-cell acute lymphoblastic leukaemia cells with activated Notch signalling. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 9 - 10). WILEY-BLACKWELL PUBLISHING, INC

Baou, M; Jewell, A; Muthurania, A; Wickremasinghe, RG; Yong, KL; Carr, R; Marsh, P; (2009) Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. LEUKEMIA , 23 (5) 986 - 989. 10.1038/leu.2008.340.

Barber, PR; Ameer-Beg, SM; Gilbey, J; Carlin, LM; Keppler, M; Ng, TC; Vojnovic, B; (2009) Multiphoton time-domain fluorescence lifetime imaging microscopy: Practical application to protein-protein interactions using global analysis. In:

Barrowcliffe, TW; Chandler, WL; Favaloro, EJ; Gardiner, C; Goodeve, A; Gray, E; Jennings, I; ... others, ; + view all (2009) Dorothy M. Adcock MD. In: UNSPECIFIED John Wiley & Sons

Bartlett, JMS; Campbell, FM; Ibrahim, M; Thomas, J; Wenyck, I; Ellis, IO; Kay, E; ... Miller, K; + view all (2009) A UK NEQAS ring study evaluating observer variation in the diagnosis of HER2 amplification using the Kreatech (TM) HER2 FISH probe. In: CANCER RESEARCH. (pp. 206S - 206S). AMER ASSOC CANCER RESEARCH

Bartlett, JMS; Campbell, FM; Ibrahim, M; Wencyk, P; Ellis, I; Kay, E; Connolly, Y; ... Miller, K; + view all (2009) Chromogenic In Situ Hybridization A Multicenter Study Comparing Silver In Situ Hybridization With FISH. AM J CLIN PATHOL , 132 (4) 514 - 520. 10.1309/AJCPXY3MJ6GSRCYP.

Bartlett, JMS; Miller, K; (2009) HER2: Closing the Gap Between Laboratory Testing and Clinical Practice Reply. AM J CLIN PATHOL , 131 (6) 898 - 899.

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; Marsh, SGE; ... Hurley, CK; + view all (2009) HLA-A Disparities Illustrate Challenges for Ranking the Impact of HLA Mismatches on Bone Marrow Transplant Outcomes in the United States. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , 15 (8) pp. 971-981. 10.1016/j.bbmt.2009.04.015.

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; Marsh, SGE; ... Hurley, CK; + view all (2009) HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. pp. 971-981.

Bazeos, A; Marin, D; Gerrard, G; Szydlo, R; Milojkovic, D; Reid, A; de Lavallade, H; ... Khorashad, JS; + view all (2009) BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 1258). AMER SOC HEMATOLOGY

Beck, S; (2009) Reverse Phenotyping: Towards an integrated (epi)genomic approach to complex phenotypes and common disease. In: JOURNAL OF MEDICAL GENETICS. (pp. S31 - S31). B M J PUBLISHING GROUP

Behjati, S; Bamfo, JEAK; Bates, AW; Veerareddy, S; (2009) A near miss: Lessons from a case of omental pregnancy. J OBSTET GYNAECOL , 29 (6) 559 - 560. 10.1080/01443610902984946.

Behjati, S; Zilbauer, M; Heuschkel, R; Phillips, A; Salvestrini, C; Torrente, F; Bates, AW; (2009) Defining Eosinophilic Colitis in Children: Insights From a Retrospective Case Series. J PEDIATR GASTR NUTR , 49 (2) 208 - 215.

Bell, CG; Beck, S; (2009) Advances in the identification and analysis of allele-specific expression. GENOME MEDICINE , 1 (ARTN 56) 10.1186/gm56.

Bell, CG; Wood, DR; Cheong, SJH; Kwan, E; Sinosich, M; Delprado, W; Baumgart, KW; (2009) Molecular confirmation of pathological specimen integrity in Australasia. Pathology , 41 (3) pp. 280-283. 10.1080/00313020902756311.

Bellodi, C; Lidonnici, MR; Hamilton, A; Helgason, GV; Soliera, AR; Ronchetti, M; Galavotti, S; ... Calabretta, B; + view all (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J CLIN INVEST , 119 (5) 1109 - 1123. 10.1172/JCI35660.

Bendall, SC; Hughes, C; Campbell, JL; Stewart, MH; Pittock, P; Liu, S; Bonneil, E; ... Lajoie, GA; + view all (2009) An Enhanced Mass Spectrometry Approach Reveals Human Embryonic Stem Cell Growth Factors in Culture. MOLECULAR & CELLULAR PROTEOMICS , 8 (3) pp. 421-432. 10.1074/mcp.M800190-MCP200.

Bergamini, G; Cigana, C; Sorio, C; Della Peruta, M; Pompella, A; Corti, A; Huaux, FA; ... Melotti, P; + view all (2009) Effects of Azithromycin on Glutathione S-Transferases in Cystic Fibrosis Airway Cells. AM J RESP CELL MOL , 41 (2) 199 - 206. 10.1165/rcmb.2008-0013OC.

Berro, M; Mayor, NP; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, JA; Shaw, BE; (2009) TGFB1 codon 10 polymorphism: Impact on outcome in allogeneic unrelated donor hematopoietic stem cell transplantation. In: TISSUE ANTIGENS. (pp. 488 - 488). WILEY-BLACKWELL PUBLISHING, INC

Bhosle, J; Makris, A; Hartley, J; Hochhauser, D; (2009) Modulation of topoisomerase II\#945; poison induced DNA damage and repair by tyrosine kinase inhibitiors. CANCER RESEARCH , 69

Bhosle, J; Makris, A; Hartley, JA; Hochhauser, D; (2009) Effect of chronic exposure to tyrosine kinase inhibitors on chemotherapy-induced DNA damage in the SKBR3 breast cancer cell line. In: CANCER RESEARCH. (pp. 117S - 117S). AMER ASSOC CANCER RESEARCH

Billottet, C; Banerjee, L; Vanhaesebroeck, B; Khwaja, A; (2009) Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation. CANCER RES , 69 (3) 1027 - 1036. 10.1158/0008-5472.CAN-08-2608.

Black, E; Glasspool, DW; Grando, MA; Patkar, V; Fox, J; (2009) Goal-Based Decisions for Dynamic Planning. In: Combi, C and Shahar, Y and AbuHanna, A, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 96 - 100). SPRINGER-VERLAG BERLIN

Boffa, MC; Cohen, H; Tincani, A; (2009) Diagnostic criteria for the obstetric antiphospholipid syndrome. In: (Proceedings) VII European Forum on antiphospholipid antibodies.

Boone, JJM; Bhosle, J; Tilby, MJ; Hartley, JA; Hochhauser, D; (2009) Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents. MOL CANCER THER , 8 (11) 3015 - 3023. 10.1158/1535-7163.MCT-09-0219.

Boshoff, C; Posner, M; (2009) Targeting EGFR in head and neck cancer: a decade of progress. NAT CLIN PRACT ONCOL , 6 (3) 123 - 123. 10.1038/ncponc1328.

Bowen, D; Groves, MJ; Burnett, AK; Patel, Y; Allen, C; Green, C; Gale, RE; ... Med Res Council Adult Leukaemia Wo, ; + view all (2009) TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. LEUKEMIA , 23 (1) 203 - 206. 10.1038/leu.2008.173.

Bowers, SR; Mirabella, F; Calero-Nieto, FJ; Valeaux, S; Hadjur, S; Baxter, EW; Merkenschlager, M; (2009) A Conserved Insulator That Recruits CTCF and Cohesin Exists between the Closely Related but Divergently Regulated Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor Genes. MOL CELL BIOL , 29 (7) 1682 - 1693. 10.1128/MCB.01411-08.

Bradshaw, TD; Stevens, MFG; Calvert, H; Plummer, ER; (2009) Preliminary clinical experiences of Phortress: Putative role for c-MET inhibition in antitumor activity. In: AMER ASSOC CANCER RESEARCH

Brewin, J; Mancao, C; Straathof, K; Karlsson, H; Samarasinghe, S; Amrolia, PJ; Pule, M; (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. BLOOD , 114 (23) pp. 4792-4803. 10.1182/blood-2009-07-228387.

Bridgewater, J; Valle, J; Palmer, D; Cunningham, D; Anthoney, D; Maraveyas, A; Hughes, S; ... Wasan, H; + view all (2009) Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): final results of the UK ABC-02 trial. In: EJC SUPPLEMENTS. (pp. 361 - 361). PERGAMON-ELSEVIER SCIENCE LTD

Brown, ACN; Hallouane, D; Mawby, WJ; Karet, FE; Saleem, MA; Howie, AJ; Toye, AM; (2009) RhCG is the major putative ammonia transporter expressed in the human kidney, and RhBG is not expressed at detectable levels. Am J Physiol Renal Physiol , 296 (6) F1279-F1290. 10.1152/ajprenal.00013.2009.

Brown, NW; Hiwarkar, P; Shaw, BE; Kulkarni, S; Saso, R; Evans, S; Treleaven, J; ... Tredger, JM; + view all (2009) Mycophenolic Acid Concentration Monitoring for Mycophenolate Mofetil-treated Graft versus Host Disease. In: THERAPEUTIC DRUG MONITORING. (pp. 663 - 663). LIPPINCOTT WILLIAMS & WILKINS

Bruce, AW; Lopez-Contreras, AJ; Flicek, P; Down, TA; Dhami, P; Dillon, SC; Koch, CM; ... Vetrie, D; + view all (2009) Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level. GENOME RES , 19 (6) 994 - 1005. 10.1101/gr.089086.108.

Brunelli, M; Manfrin, E; Martignoni, G; Miller, K; Remo, A; Reghellin, D; Bersani, S; ... Bonetti, F; + view all (2009) Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification. AM J CLIN PATHOL , 131 (5) 678 - 682. 10.1309/AJCP09VUTZWZXBMJ.

Bruno, L; Mazzarella, L; Hoogenkamp, M; Hertweck, A; Cobb, BS; Sauer, S; Hadjur, S; ... Merkenschlager, M; + view all (2009) Runx proteins regulate Foxp3 expression. J EXP MED , 206 (11) 2329 - 2337. 10.1084/jem.20090226.

Bucciarelli-Ducci, C; Lyne, J; Reyes, E; Assomull, R; Petryka, J; Watkins, S; Gatehouse, P; ... Pennell, D; + view all (2009) Diagnostic Performance of Perfusion Cardiovascular Magnetic Resonance Compared With Gated Myocardial Perfusion SPECT in Patients With Known or Suspected Coronary Artery Disease. In: CIRCULATION. (pp. S1094 - S1094). LIPPINCOTT WILLIAMS & WILKINS

C

CRT, ; Stoeber, K; Williams, GH; (2009) Diagnostic, predictive and prognostic testing for cancer. WO/2009/050461.

Calvaruso, V; Burroughs, AK; Standish, R; Manousou, P; Grillo, F; Leandro, G; Maimone, S; ... Dhillon, AP; + view all (2009) Computer-Assisted Image Analysis of Liver Collagen: Relationship to Ishak Scoring and Hepatic Venous Pressure Gradient. HEPATOLOGY , 49 (4) 1236 - 1244. 10.1002/hep.22745.

Cantu, C; Ierardi, R; Fugazza, C; Grande, V; Alborelli, I; Ottolenghi, S; Ferrari, G; (2009) SOX6 OVEREXPRESSION IN HUMAN ERYTHROID PROGENITORS STRONGLY ENHANCES THEIR TERMINAL MATURATION. In: (Proceedings) 38th Annual Scientific Meeting of the ISEH-Society-for-Hematology-and-Stem-Cells. (pp. S12-S12). ELSEVIER SCIENCE INC

Cappellini, MD; Perrotta, S; Agaoglu, L; Aydinok, Y; Capra, M; Canatan, D; Drelichman, G; ... Kattamis, A; + view all (2009) Efficacy and Safety of Deferasirox (Exjade (R)) in Patients with beta-Thalassemia Major Treated for up to 5 Years. In: BLOOD. (pp. 1558 - 1559). AMER SOC HEMATOLOGY

Carle, D; Bielack, S; Sydes, M; Butterfass-Bahloul, T; Calaminus, G; Jovic, G; Marina, N; ... Bernstein, M; + view all (2009) The European and American Osteosarcoma Study Group protocol EURAMOS 1: Successful transatlantic cooperation in osteosarcoma. In:

Carpenter, JP; Alpendurada, F; Deac, M; Kirk, P; Porter, JB; Walker, JM; Banya, W; ... Pennell, DJ; + view all (2009) Impact of Myocardial Iron Loading On Right Ventricular Function. In: BLOOD. (pp. 794 - 794). AMER SOC HEMATOLOGY

Cave, J; Edwards, SG; Miller, RF; Ardeshna, KM; Lee, SM; (2009) Should we implement 'opt-out' HIV testing for patients with lymphoma? Clinical Medicine , 9 (4) 320 - 322. 10.7861/clinmedicine.9-4-320.

Chacko, S; Taskapan, H; Roscoe, J; Stein, J; Woods, E; Denton, T; Ting, R; ... Sikaneta, T; + view all (2009) Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen - case report and review of the literature. Clin Nephrol , 72 (5) pp. 414-417.

Chaffe, B; Jones, J; Milkins, C; Taylor, C; Asher, D; Glencross, H; Murphy, M; ... Collaborative, UKTL; + view all (2009) UK transfusion laboratory collaborative: recommended minimum standards for hospital transfusion laboratories. Transfusion medicine , 19 pp. 156-158.

Chan, CF; Gatehouse, PD; Hughes, R; Roughton, M; Pennell, DJ; Firmin, DN; (2009) Novel Technique Used to Detect Swallowing in Volume-Selective Turbo Spin-Echo (TSE) for Carotid Artery Wall Imaging. J MAGN RESON IMAGING , 29 (1) 211 - 216. 10.1002/jmri.21607.

Chanalaris, A; Grace, C; Gale, R; Linch, D; Nacheva, EP; (2009) GENOME PROFILING OF NORMAL KARYOTYPE AML WITH HIGH DENSITY ARRAY COMPARATIVE GENOME HYBRIDISATION. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 114 - 114). FERRATA STORTI FOUNDATION Gold open access

Chapgier, A; Kong, X-F; Boisson-Dupuis, S; Jouanguy, E; Averbuch, D; Feinberg, J; Zhang, S-Y; ... Casanova, J-L; + view all (2009) A partial form of recessive STAT1 deficiency in humans. JOURNAL OF CLINICAL INVESTIGATION , 119 (6) pp. 1502-1514. 10.1172/JCI37083.

Chapman, CE; Stainsby, D; Jones, H; Love, E; Massey, E; Win, N; Navarrete, C; ... Serious Hazards of Transfusion Steering Group, ; + view all (2009) Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion , 49 (3) pp. 440-452. 10.1111/j.1537-2995.2008.01948.x.

Charolidi, N; Cynthia, LA; Signore, M; Richard, GJ; Martinez-Barbera, JP; (2009) Developmental regulatory targets of the homeobox transcription factor HESX1. Mechanisms of Development , 126 (Supple) S117 - S117. 10.1016/j.mod.2009.06.220. Green open access
file

Cheng, YY; Siddle, HV; Beck, S; Eldridge, MDB; Belov, K; (2009) High levels of genetic variation at MHC class II DBB loci in the tammar wallaby (Macropus eugenii). IMMUNOGENETICS , 61 (2) 111 - 118. 10.1007/s00251-008-0347-6.

Cheng, YY; Wakefield, M; Siddle, HV; Coggill, PC; Herbert, CA; Beck, S; Belov, K; (2009) Isolation and characterization of 10 MHC Class I-associated microsatellite loci in tammar wallaby (Macropus eugenii). MOL ECOL RESOUR , 9 (1) 346 - 349. 10.1111/j.1755-0998.2008.02401.x.

Cheung, CW; Khwaja, A; (2009) Stromal cell-mediated drug resistance in acute myeloid leukaemia (AML) is attenuated by PI103, a dual inhibitor of Class I PI3-Kinase (PI3K) and mTOR. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 2 - 2). WILEY-BLACKWELL PUBLISHING, INC

Chew, SK; Chen, P; Link, N; Galindo, KA; Pogue, K; Abrams, JM; (2009) Genome-wide silencing in Drosophila captures conserved apoptotic effectors. Nature , 460 (7251) pp. 123-127. 10.1038/nature08087.

Chickarmane, V; Enver, T; Peterson, C; (2009) Computational Modeling of the Hematopoietic Erythroid-Myeloid Switch Reveals Insights into Cooperativity, Priming, and Irreversibility. PLOS COMPUT BIOL , 5 (1) , Article e1000268. 10.1371/journal.pcbi.1000268. Green open access
file

Chua, MLK; Kamis, HB; Loong, SL; (2009) In vitro interaction of cyclooxygenase-2 (COX-2) inhibitors with radiation in nasopharyngeal carcinoma: dependent on sequence of administration. In: ORAL ONCOLOGY. (pp. 236 - 236). ELSEVIER SCIENCE BV

Chua, MLK; Ong, SC; Wee, JTS; Ng, DCE; Gao, F; Tan, TWK; Fong, KW; ... Low, JSH; + view all (2009) COMPARISON OF 4 MODALITIES FOR DISTANT METASTASIS STAGING IN ENDEMIC NASOPHARYNGEAL CARCINOMA. HEAD NECK-J SCI SPEC , 31 (3) 346 - 354. 10.1002/hed.20974.

Chua, YL; Ito, Y; Pole, JCM; Newman, S; Chin, S-F; Stein, RC; Ellis, IO; ... Edwards, PAW; + view all (2009) The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. ONCOGENE , 28 (46) pp. 4041-4052. 10.1038/onc.2009.259.

Cliffe, ST; Kramer, JM; Hussain, K; Robben, JH; de Jong, EK; de Brouwer, AP; Nibbeling, E; ... Buckley, MF; + view all (2009) SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. HUM MOL GENET , 18 (12) 2257 - 2265. 10.1093/hmg/ddp161.

Coccia, M; Brooks, SP; Webb, TR; Christodoulou, K; Wozniak, IO; Murday, V; Balicki, M; ... Hardcastle, AJ; + view all (2009) X-linked cataract and Nance-Horan syndrome are allelic disorders. Hum Mol Genet , 18 (14) pp. 2643-2655.

Cohen, H; (2009) Anticoagulation: quality and safety indicators. [Lecture]. Presented at: Institute of healthcare management, London.

Cohen, H; (2009) Effectively implementing the NPSA safety alert. [Lecture]. Presented at: Institute of healthcare management conference on medication errors, London.

Cohen, H; (2009) Late obstetric morbidity in antiphospholipid syndrome. Presented at: VII European Forum on antiphospholipid antibodies, Marseilles.

Cohen, H; (2009) SHOT data 2008 Part 1. [Lecture]. Presented at: SHOT annual symposium, Royal Society of Medicine, London.

Cohen, H; Baglin, T; (2009) Plasma, plasma products and indications for their use. In: Contreras, M, (ed.) ABC of transfusion medicine: british medical journal books. (pp. 40-47). Wiley-Blackwell

Cohen, H; Gates, C; (2009) Anticoagulation therapy: quality and safety indicators. [Lecture]. Presented at: Institute of healthcare management, Manchester.

Cohen, H; Gates, C; (2009) Anticoagulation with dabigatran or rivaroxaban. Drugs and Therapeutics Bulletin , 47 pp. 116-120.

Cohen, H; Gates, C; (2009) New oral agents vs subcutaneous alternatives. Has the DTB drawn the correct conclusion? BMJ online

Cohen-Solal, A; Kotecha, D; van Veldhuisen, DJ; Babalis, D; Bohm, M; Coats, AJ; Roughton, M; ... SENIORS Investigators, ; + view all (2009) Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. EUR J HEART FAIL , 11 (9) 872 - 880. 10.1093/eurjhf/hfp104.

Collins, GP; Paterson, JC; Campbell, L; Mason, DY; Enver, T; Marafioti, T; (2009) EXPRESSION AND EPIGENETIC ANALYSIS OF KEY B-LINEAGE TRANSCRIPTIONAL PROGRAMMES IN HODGKIN/REED-STERNBERG CELLS. In: (Proceedings) 14th Annual Meeting of the European-Hematology-Association. (pp. p. 36). FERRATA STORTI FOUNDATION Gold open access

Constantinou, A; Epenetos, AA; Hreczuk-Hirst, D; Jain, S; Wright, M; Chester, KA; Deonarain, MP; (2009) Site-Specific Polysialylation of an Antitumor Single-Chain Fv Fragment. BIOCONJUGATE CHEM , 20 (5) 924 - 931. 10.1021/bc8005122.

Cooley, S; Guethlein, L; Trachtenberg, E; Ladner, M; Luo, X; Le, CT; Wang, T; ... Miller, JS; + view all (2009) Selection of Donors with Favorable KIR B Genotypes for Unrelated Hematopoietic Cell Transplantation Results in Superior Relapse Protection and Better Relapse-Free Survival for Patients with AML. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. pp. 277-278). AMER SOC HEMATOLOGY

Cooley, S; Parham, P; Trachtenberg, E; Luo, X; Le, CT; Klein, J; Marsh, SGE; ... Miller, JS; + view all (2009) THE RELAPSE-FREE SURVIVAL BENEFIT ASSOCIATED WITH GROUP B KIR HAPLOTYPE DONORS FOR UNRELATED HEMATOPOIETIC CELL TRANSPLANTATION IS UNIQUE TO ACUTE MYELOGENOUS LEUKEMIA. In: (Proceedings) Tandem Meeting on Biology of Blood and Marrow Transplantation. (pp. p. 3). ELSEVIER SCIENCE INC

Cooley, S; Trachtenberg, E; Bergemann, TL; Saeteurn, K; Klein, J; Le, CT; Marsh, SGE; ... Weisdorf, DJ; + view all (2009) Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. BLOOD , 113 (3) pp. 726-732. 10.1182/blood-2008-07-171926.

Cowie, MR; Nicol, ED; Fittall, B; Roughton, M; Cleland, JGF; Dargie, H; (2009) Heart failure in the UK Reply. HEART , 95 (2) 156 - 157.

Croucher, C; Whelan, JS; Møller, H; Davies, EA; (2009) Trends in the incidence and survival of cancer in teenagers and young adults: Regional analysis for South East England 1960 - 2002. Clinical Oncology , 21 pp. 417-424.

Cunningham, D; Sirohi, B; Pluzanska, A; Utracka-Hutka, B; Zaluski, J; Glynne-Jones, R; Koralewski, P; ... Cassidy, J; + view all (2009) Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer. ANNALS OF ONCOLOGY , 20 (2) pp. 244-250. 10.1093/annonc/mdn638.

Cybulla, M; Walter, KN; Schwarting, A; DiVito, R; Feriozzi, S; Sunder-Plassmann, G; (2009) Kidney transplantation in patients with Fabry disease. TRANSPLANT INTERNATIONAL , 22 (4) pp. 475-481. 10.1111/j.1432-2277.2008.00824.x.

D

Dalby, M; Kharbanda, R; Ghimire, G; Spiro, J; Moore, P; Roughton, M; Lane, R; ... Ilsley, C; + view all (2009) Achieving routine sub 30 minute door-to-balloon times in a high volume 24/7 primary angioplasty center with autonomous ambulance diagnosis and immediate catheter laboratory access. AM HEART J , 158 (5) 829 - 835. 10.1016/j.ahj.2009.08.012.

Dancey, G; Begent, RH; Meyer, T; (2009) Imaging in targeted delivery of therapy to cancer. TARGET ONCOL , 4 (3) 201 - 217. 10.1007/s11523-009-0119-8.

Dancey, G; Violet, J; Malaroda, A; Green, AJ; Sharma, SK; Francis, R; Othman, S; ... McNamara, C; + view all (2009) A Phase I Clinical Trial of CHT-25 a I-131-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. CLIN CANCER RES , 15 (24) 7701 - 7710. 10.1158/1078-0432.CCR-09-1421.

Dar, O; Riley, J; Chapman, C; Dubrey, SW; Morris, S; Rosen, SD; Roughton, M; (2009) A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study. EUR J HEART FAIL , 11 (3) 319 - 325. 10.1093/eurjhf/hfn050.

Davies, TD; Taylor, C; Jones, H; Cohen, H; (2009) Serious hazards of transfusion (SHOT) near miss reporting. In: (Proceedings) British society for haematology annual scientific meeting.

Davies, TD; Taylor, C; Jones, H; Cohen, H; (2009) Serious hazards of transfusion (SHOT) reports relating to anti-D immunoglobulin. In: (Proceedings) British society for haematology annual scientific meeting.

Davis, R; Sielaff, A; Ruprich, J; Westrate, L; Tronrud, C; Ferguson, A; Brown, T; ... Lee, M; + view all (2009) Design, synthesis, biophysical and biological studies of fluorescent Hoechst-polyamide hybrid molecules. ABSTR PAP AM CHEM S , 237 ? - ?.

Dearling, JLJ; Flynn, AA; Qureshi, U; Whiting, S; Boxer, GM; Green, A; Begent, RHJ; (2009) Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake. NUCL MED BIOL , 36 (8) 883 - 894. 10.1016/j.nucmedbio.2009.07.003.

Delaney, D; Diss, TC; Presneau, N; Hing, S; Berisha, F; Idowu, BD; O'Donnell, P; ... Flanagan, AM; + view all (2009) GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. MODERN PATHOL , 22 (5) 718 - 724. 10.1038/modpathol.2009.32.

Denard, J; Rundwasser, S; Laroudie, N; Gonnet, F; Naldini, L; Radrizzani, M; Galy, A; ... Svinartchouk, F; + view all (2009) Quantitative proteomic analysis of lentiviral vectors using 2-DE. Proteomics , 9 (14) pp. 3666-3676. 10.1002/pmic.200800747.

Dennis, MY; Paracchini, S; Scerri, TS; Prokunina-Olsson, L; Knight, JC; Wade-Martins, R; Coggill, P; ... Monaco, AP; + view all (2009) A Common Variant Associated with Dyslexia Reduces Expression of the KIAA0319 Gene. PLOS GENET , 5 (3) , Article e1000436. 10.1371/journal.pgen.1000436. Green open access
file

Desai, K; Bhattacharya, S; Srirajaskanthan, R; Morgan-Rowe, L; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Analysis of association between carcinoid heart disease and mesenteric fibrosis in patients with midgut carcinoid tumour. In: (Proceedings) 45th Annual Meeting of the American-Society-of-Clinical-Oncology. AMER SOC CLINICAL ONCOLOGY

Desai, K; Bhattacharya, S; Srirajaskanthan, R; Morgan-Rowe, L; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Analysis of association between carcinoid heart disease and mesenteric fibrosis in patients with midgut carcinoid tumour. J Clin Oncol , 27 (15_suppl) , Article e15650.

Dignan, FL; Anthias, C; Ethell, ME; Morilla, R; Morilla, A; Davies, FE; Morgan, GJ; ... Shaw, BE; + view all (2009) The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia. In: BLOOD. (pp. 1020 - 1021). AMER SOC HEMATOLOGY

Dignan, FL; Evans, SO; Ethell, ME; Shaw, BE; Davies, FE; Dearden, CE; Treleaven, JG; ... Potter, MN; + view all (2009) An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. BONE MARROW TRANSPL , 44 (1) 51 - 56. 10.1038/bmt.2008.427.

Ding, XY; Patel, M; Shen, DF; Herzlich, AA; Cao, XG; Villasmil, R; Klupsch, K; ... Chan, CC; + view all (2009) Enhanced HtrA2/Omi Expression in Oxidative Injury to Retinal Pigment Epithelial Cells and Murine Models of Neurodegeneration. INVEST OPHTH VIS SCI , 50 (10) 4957 - 4966. 10.1167/iovs.09-3381.

Dovey, CL; Aslanian, A; Sofueva, S; Yates, JR; Russell, P; (2009) Mms1-Mms22 complex protects genome integrity in Schizosaccharomyces pombe. DNA REPAIR , 8 (12) 1390 - 1399. 10.1016/j.dnarep.2009.09.008.

Dulev, S; de Renty, C; Mehta, R; Minkov, I; Schwob, E; Strunnikov, A; (2009) Essential global role of CDC14 in DNA synthesis revealed by chromosome underreplication unrecognized by checkpoints in cdc14 mutants. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 106 (34) pp. 14466-14471. 10.1073/pnas.0900190106.

Dunn, JM; Fullarton, G; Thorpe, S; Novelli, M; Bown, SG; Lovat, LB; (2009) RADIOFREQUENCY ABLATION OF HIGH-GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS AFTER FAILED PHOTODYNAMIC THERAPY: FIRST RESULTS OF THE UK HALO RADIOFREQUENCY ABLATION REGISTRY. In: (pp. PT286-).

Dunn, JM; Fullarton, GM; Thorpe, S; Novelli, M; Bown, SG; Lovat, L; (2009) Radiofrequency Ablation of High Grade Dysplasia in Barrett's Oesophagus Is Safe and Effective After Failed Photodynamic Therapy - First Results of the UK HALO RFA Registry. In: GASTROINTESTINAL ENDOSCOPY. (pp. AB260 - AB260). MOSBY-ELSEVIER

Dunn, JM; Mackenzie, GD; Oukrif, D; Green, SJ; Chew, Y; Mosse, CA; Thorpe, S; ... Lovat, L; + view all (2009) DNA Ploidy As a Prognostic Biomarker After Ala Photodynamic Therapy for High Grade Dysplasia in Barrett's Oesophagus. In: GASTROENTEROLOGY. (pp. A49 - A49). W B SAUNDERS CO-ELSEVIER INC

Dunn, JM; Mackenzie, GD; Oukrif, D; Mosse, CA; Green, S; Chew, Y; Thorpe, S; ... Lovat, LB; + view all (2009) DNA PLOIDY AS A PROGNOSTIC BIOMARKER AFTER AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR HIGH-GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. In: GUT. (pp. A111 - A112). B M J PUBLISHING GROUP

Dunn, JM; Mackenzie, GD; Oukrif, D; Mosse, CA; Green, S; Chew, Y; Thorpe, S; ... Lovat, LB; + view all (2009) DNA PLOIDY AS A PROGNOSTIC BIOMARKER AFTER AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR HIGH-GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS. In: (pp. PT285-).

Dunn, JM; Thorpe, S; Novelli, M; Bown, SG; Lovat, L; (2009) Radiofrequency Ablation for the Treatment of Squamous High Grade Dysplasia of the Oesophagus- First Reported Series. In: GASTROINTESTINAL ENDOSCOPY. (pp. AB255 - AB255). MOSBY-ELSEVIER

Durand, CA; Hartvigsen, K; Fogelstrand, L; Kim, S; Iritani, S; Vanhaesebroeck, B; Witztum, JL; ... Gold, MR; + view all (2009) Phosphoinositide 3-Kinase p110 delta Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses. JOURNAL OF IMMUNOLOGY , 183 (9) pp. 5673-5684. 10.4049/jimmunol.0900432.

de Bono, JS; Brunetto, A; Kristeleit, RS; Mais, A; Hauns, B; Hentsch, B; (2009) Clinical and preclinical development of 4SC-201, a new oral histone deacetylase (HDAC) inhibitor. European journal of cancer , 7 (2) p. 137.

de Fabiani, E; Gilardi, F; Galmozzi, A; Boraso, M; Bartesaghi, S; Torri, A; Caruso, D; ... Marinovich, M; + view all (2009) EXPRESSION OF STEROL 27-HYDROXYLASE IN GLIAL CELLS AND ITS REGULATION BY LIVER X RECEPTOR SIGNALING. In: GLIA. (pp. S51 - S51). WILEY-LISS

E

Edinger, M; Powrie, F; Chakraverty, R; (2009) Regulatory Mechanisms in Graft-versus-Host Responses. Biology of Blood and Marrow Transplantation , 15 (1 SUPPL.) pp. 2-6. 10.1016/j.bbmt.2008.10.013.

El-Mehidi, N.S.; (2009) Bayesian network models of interdependent chromosomal aberrations in unstable cancer genomes. Doctoral thesis , UCL (University College London).

Ella, W; Short, SC; (2009) Using retinoids to increase radio-iodine uptake in thyroid cancer: role as potential redifferentiation agents. In: The handbook on iodine. Elsevier

Emuss, V; Lagos, D; Pizzey, A; Gratrix, F; Henderson, SR; Boshoff, C; (2009) KSHV Manipulates Notch Signaling by DLL4 and JAG1 to Alter Cell Cycle Genes in Lymphatic Endothelia. PLoS Pathogens , 5 (10) , Article e1000616. 10.1371/journal.ppat.1000616. Green open access
file

Endrighi, R; Hamer, M; O'Donnell, K; Steptoe, A; (2009) Optimism is associated with lower daily cortisol production in healthy older men and women. PSYCHOLOGY & HEALTH , 24 pp. 163-164.

Enver, T; Jacobsen, SEW; (2009) DEVELOPMENTAL BIOLOGY Instructions writ in blood. NATURE , 461 (7261) pp. 183-184. 10.1038/461183a.

Enver, T; Pera, M; Peterson, C; Andrews, PW; (2009) Stem Cell States, Fates, and the Rules of Attraction. CELL STEM CELL , 4 (5) pp. 387-397. 10.1016/j.stem.2009.04.011.

Essafi, A; Gomes, AR; Pomeranz, KM; Zwolinska, AK; Varshochi, R; McGovern, UB; Lam, EW-F; (2009) Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt. Methods Mol Biol , 462 pp. 201-211. 10.1007/978-1-60327-115-8_13.

Everington, T.; (2009) Investigation of the molecular and functional pathophysiology of polycythaemia vera. Doctoral thesis , UCL (University College London).

F

FOLEY, JH; NESHEIM, ME; (2009) Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor. Journal of Thrombosis and Haemostasis , 7 (3) pp. 453-459. 10.1111/j.1538-7836.2008.03261.x.

Fallah-Arani, F; Sivakumaran, J; Flutter, BR; Bennett, C; Chakraverty, R; (2009) Host CD11c(+) Dendritic Cells Are Required for Priming the Lympho-Haematopoietic Graft-Versus-Host Response but Not Graft-Versus-Host Disease. In: BLOOD. (pp. 966 - 967). AMER SOC HEMATOLOGY

Fazel, MZ; Gogalniceanu, P; Patel, A; Capitano, A; Kocjan, G; Falzon, M; Douek, M; (2009) Intra-operative touch imprint cytology for assessing sentinel lymph nodes in patients with lobular breast cancer. In: CANCER RESEARCH. (pp. 108S - 108S). AMER ASSOC CANCER RESEARCH

Fern, L; Ashton, J; Broonan, K; Irving, C; Millington, H; Starkey, C; Wright, D; (2009) Involving young people with cancer in research. The National Cancer Research Institute’s Teeange and Young Adult Core Consumer Group – a new and evolving model. In:

Fielding, AK; Rowe, JM; Richards, SM; Buck, G; Moorman, AV; Durrant, IJ; Marks, DI; ... Goldstone, AH; + view all (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. BLOOD , 113 (19) 4489 - 4496. 10.1182/blood-2009-01-199380.

Finerty, MJ; Bingham, JP; Hartley, JA; Shipman, M; (2009) Azinomycin bisepoxides containing rigid aromatic linkers: synthesis, cytotoxicity and DNA interstrand cross-linking activity. TETRAHEDRON LETT , 50 (26) 3648 - 3650. 10.1016/j.tetlet.2009.03.123.

Fiore, MM; Mackie, IJ; (2009) Dual effect of Platelet Factor 4 on the activities of Factor Xa. BIOCHEM BIOPH RES CO , 379 (4) 1072 - 1075. 10.1016/j.bbrc.2009.01.016.

Fiore, MM; Mackie, IM; (2009) Mechanism of low-molecular-weight heparin reversal by platelet factor 4. THROMBOSIS RESEARCH , 124 (1) pp. 149-155. 10.1016/j.thromres.2008.12.047.

Flanagan, JM; Funes, JM; Henderson, S; Wild, L; Carey, N; Boshoff, C; (2009) Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. MOL CANCER THER , 8 (1) 249 - 260. 10.1158/1535-7163.MCT-08-0636.

Flanagan, JM; Munoz-Alegre, M; Henderson, S; Tang, T; Sun, P; Johnson, N; Fletcher, O; ... Petronis, A; + view all (2009) Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. HUM MOL GENET , 18 (7) 1332 - 1342. 10.1093/hmg/ddp033.

Fong, LY; Wan, SG; Taccioli, C; Jiang, YB; Liu, XP; Croce, CM; Farber, JL; (2009) Zinc Deficiency Induces Upregulation of S100A8/A9 and Abolishes the Anticancer Effects of COX-2 Disruption in Murine Oral-Esophageal Cancer Prevention. J NUTRIGENET NUTRIGE , 2 (4-5) 211 - 211.

Ford, AM; Palmi, C; Bueno, C; Hong, D; Cardus, P; Knight, D; Cazzaniga, G; ... Greaves, M; + view all (2009) The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. JOURNAL OF CLINICAL INVESTIGATION , 119 (4) pp. 826-836. 10.1172/JCI36428.

Foroni, L; Gerrard, G; Nna, E; Khorashad, JS; Stevens, D; Swale, B; Milojkovic, D; ... Marin, D; + view all (2009) Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY , 84 (8) pp. 517-522. 10.1002/ajh.21457.

Forshew, T; Tatevosslan, RG; Lawson, ARJ; Ma, J; Neale, G; Ogunkolade, BW; Jones, TA; ... Sheer, D; + view all (2009) Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. JOURNAL OF PATHOLOGY , 218 (2) pp. 172-181. 10.1002/path.2558.

Fox, J; Patkar, V; Chronakis, I; Begent, R; (2009) From practice guidelines to clinical decision support: closing the loop. J ROY SOC MED , 102 (11) 464 - 473. 10.1258/jrsm.2009.090010.

Francis, RE; Myatt, SS; Krol, J; Hartman, J; Peck, B; McGovern, UB; Wang, J; ... Lam, EW-F; + view all (2009) FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol , 35 (1) pp. 57-68.

G

GUPTA, R; Vyas, P; Enver, T; (2009) Molecular targeting of cancer stem cells. Cell Stem Cell , 5 (2) pp. 125-126. 10.1016/j.stem.2009.07.006.

Gancheva, K; Postadjian, A; Brazma, D; Grace, C; Chanalaris, A; Nacheva, E; Apostolova, MD; (2009) COPY NUMBER VARIANTS: DISTRIBUTION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS. BIOTECHNOL BIOTEC EQ , 23 (1) 1095 - 1100.

Gandhi, S; Wood-Kaczmar, A; Yao, Z; Plun-Favreau, H; Deas, E; Klupsch, K; Downward, J; ... Abramov, AY; + view all (2009) PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death. MOL CELL , 33 (5) 627 - 638. 10.1016/j.molcel.2009.02.013. Gold open access

Garbowski, MW; Carpenter, JP; Smith, G; Pennell, DJ; Porter, JB; (2009) Calibration of Improved T2*Method for the Estimation of Liver Iron Concentration in Transfusional Iron Overload. In: BLOOD. (pp. 791 - 791). AMER SOC HEMATOLOGY

Garbowski, MW; Fabre, M; Evans, P; Porter, JB; (2009) Vitamin C Status in Transfusionally Iron-Overloaded Patients On Long-Term Deferasirox and Its Relationship to Myocardial Iron Removal. In: BLOOD. (pp. 792 - 792). AMER SOC HEMATOLOGY

Gardiner, C; Longair, I; Pescott, MA; Erwin, H; Hills, J; Machin, SJ; Cohen, H; (2009) Self-monitoring of oral anticoagulation: does it work outside trial conditions? Journal of Clinical Pathology , 62 (2) 168 - 171. 10.1136/jcp.2008.059634. Green open access
file

Gardiner, C; Machin, S; Mackie, I; (2009) Point-of-Care Testing in Hemostasis. In: Quality in Laboratory Hemostasis and Thrombosis. (pp. 72-80).

Garofalo, M; Di Leva, G; Romano, G; Nuovo, G; Suh, SS; Ngankeu, A; Taccioli, C; ... Croce, CM; + view all (2009) miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. CANCER CELL , 16 (6) 498 - 509. 10.1016/j.ccr.2009.10.014.

Gaya, A.M.; (2009) Combination therapy studies with the vascular disruptive agent combretastatin-a4-phosphate (CA4P). Doctoral thesis , UCL (University College London). Green open access
file

Gennarino, VA; Sardiello, M; Avellino, R; Meola, N; Maselli, V; Anand, S; Cutillo, L; ... Banfi, S; + view all (2009) MicroRNA target prediction by expression analysis of host genes. pp. 481-490.

George, S; Lal, R; Camidge, DR; Arkenau, H; Chick, J; Poondru, S; Yap, TA; ... Scurr, M; + view all (2009) Final results of a dose escalation (DE), pharmacokinetic (PK), and pharmacodynamic (PD) study of two schedules of OSI-930 in patients (pts) with advanced solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, AB; (2009) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. EUROPEAN JOURNAL OF PHARMACOLOGY , 609 (1-3) pp. 34-39. 10.1016/j.ejphar.2009.03.018.

Ghimire, G; Spiro, J; Kharbanda, R; Roughton, M; Barlis, P; Mason, M; Ilsley, C; ... Dalby, M; + view all (2009) Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention , 4 (4) pp. 481-484.

Ghosh, AK; Shanafelt, TD; Cimmino, A; Taccioli, C; Volinia, S; Liu, CG; Calin, GA; ... Kay, NE; + view all (2009) Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. BLOOD , 113 (22) 5568 - 5574. 10.1182/blood-2008-10-185686.

Giampieri, S; Manning, C; Hooper, S; Jones, L; Hill, CS; Sahai, E; (2009) Localized and reversible TGF beta signalling switches breast cancer cells from cohesive to single cell motility. NAT CELL BIOL , 11 (11) 1287 - U49. 10.1038/ncb1973.

Gibson, F; Aldiss, S; Taylor, RM; Maguire, R; Kearney, N; (2009) Involving health professionals in the development of an advanced symptom management system for young people: The ASyMS (c)-YG study. EUR J ONCOL NURS , 13 (3) 187 - 192. 10.1016/j.ejon.2009.03.004.

Gibson, F; Pearce, S; Eden, T; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2009) CANCER IN YOUNG PEOPLE: A NARRATIVE STUDY TO EXPLORE THEIR EXPERIENCE FROM FIRST SYMPTOMS TO THE DIAGNOSIS OF CANCER. In: PEDIATR BLOOD CANCER. (pp. 751 - 751). WILEY-LISS

Gikas, PD; Islam, L; Aston, W; Tirabosco, R; Saifuddin, A; Briggs, TWR; Cannon, SR; ... Flanagan, AM; + view all (2009) Nonbacterial osteitis: a clinical, histopathological, and imaging study with a proposal for protocol-based management of patients with this diagnosis. J ORTHOP SCI , 14 (5) 505 - 516. 10.1007/s00776-009-1381-4.

Gilardi, F; Viviani, B; Galmozzi, A; Boraso, M; Bartesaghi, S; Torri, A; Caruso, D; ... de Fabiani, E; + view all (2009) EXPRESSION OF STEROL 27-HYDROXYLASE IN GLIAL CELLS AND ITS REGULATION BY LIVER X RECEPTOR SIGNALING. NEUROSCIENCE , 164 (2) 530 - 540. 10.1016/j.neuroscience.2009.08.003.

Gollmer, K; Asperti-Boursin, F; Tanaka, Y; Okkenhaug, K; Vanhaesebroeck, B; Peterson, JR; Fukui, Y; ... Stein, JV; + view all (2009) CCL21 mediates CD4(+) T-cell costimulation via a DOCK2/Rac-dependent pathway. BLOOD , 114 (3) pp. 580-588. 10.1182/blood-2009-01-200923.

Gordon, WR; Roy, M; Vardar-Ulu, D; Garfinkel, M; Mansour, MR; Aster, JC; Blacklow, SC; (2009) Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. BLOOD , 113 (18) pp. 4381-4390. 10.1182/blood-2008-08-174748.

Gourley, C; Paige, AJW; Taylor, KJ; Ward, C; Kuske, B; Zhang, J; Sun, M; ... Gabra, H; + view all (2009) WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Res , 69 (11) pp. 4835-4842. 10.1158/0008-5472.CAN-08-2974.

Graf, T; Enver, T; (2009) Forcing cells to change lineages. NATURE , 462 (7273) pp. 587-594. 10.1038/nature08533.

Green, CL; Koo, KK; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2009) PROGNOSTIC SIGNIFICANCE OF CEBPA MUTATIONS IN A LARGE COHORT OF YOUNGER ADULT PATIENTS WITH AML: IMPACT OF DOUBLE CEBPA MUTATIONS AND THE INTERACTION WITH FLT3 AND NPM1 MUTATIONS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 431 - 431). FERRATA STORTI FOUNDATION Gold open access

Grimwade, D; Jovanovic, JV; Hills, RK; Nugent, EA; Patel, Y; Flora, R; Diverio, D; ... Burnett, AK; + view all (2009) Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy. J CLIN ONCOL , 27 (22) 3650 - 3658. 10.1200/JCO.2008.20.1533.

Grun, B; Benjamin, E; Sinclair, J; Timms, JF; Jacobs, IJ; Gayther, SA; Dafou, D; (2009) Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. CELL PROLIFERAT , 42 (2) 219 - 228. 10.1111/j.1365-2184.2008.00579.x.

Gunaratnam, M; Green, C; Moreira, JB; Moorhouse, AD; Kelland, LR; Moses, JE; Neidle, S; (2009) G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo. BIOCHEMICAL PHARMACOLOGY , 78 (2) pp. 115-122. 10.1016/j.bcp.2009.03.018.

Gunaratnam, M; Swank, S; Haider, SM; Galesa, K; Reszka, AP; Beltran, M; Cuenca, F; ... Neidle, S; + view all (2009) Targeting Human Gastrointestinal Stromal Tumor Cells with a Quadruplex-Binding Small Molecule. JOURNAL OF MEDICINAL CHEMISTRY , 52 (12) pp. 3774-3783. 10.1021/jm900424a.

Gupta, R; Vyas, P; Enver, T; (2009) Molecular Targeting of Cancer Stem Cells. CELL STEM CELL , 5 (2) pp. 125-126. 10.1016/j.stem.2009.07.006.

H

Haas, TL; Emmerich, CH; Gerlach, B; Schmukle, AC; Cordier, SM; Rieser, E; Feltham, R; ... Walczak, H; + view all (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell , 36 pp. 831-844. 10.1016/j.molcel.2009.10.013.

Hackshaw, A; (2009) Luteinizing hormone-releasing hormone (LHRH) agonists in the treatment of breast cancer. Expert Opinion on Pharmacotherapy , 10 (16) pp. 1-7.

Hackshaw, A; (2009) A concise guide to clinical trials. [Book]. (1st ed.). BMJ Books (Blackwell & John Wiley Publishing)

Hackshaw, A; (2009) The NCRI prospective randomised trial of high (standard) versus low dose 131I ablation with or without recombinant TSH (HiLo). In: Miles, A, (ed.) The effective management of head, neck and thyroid cancer. UK Key Advances in Clinical Practice. Aesculapius Medical Press (In press).

Hackshaw, A; Baum, M; Fornander, T; Nordenskjold, B; Nicolucci, A; Monson, K; Forsyth, S; ... Sainsbury, R; + view all (2009) Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer. J NATL CANCER I , 101 (5) 341 - 349. 10.1093/jnci/djn498. Green open access
file

Hackshaw, AK; Mallick, U; (2009) Low versus high I-131 dose for remnant ablation in differentiated thyroid cancer. Clinical Medicine and Research , 7 (1/2) pp. 1-3.

Hadjur, S; Bruno, L; Hertweck, A; Cobb, BS; Taylor, B; Fisher, AG; Merkenschlager, M; (2009) IL4 blockade of inducible regulatory T cell differentiation: The role of Th2 cells, Gata3 and PU.1. IMMUNOL LETT , 122 (1) 37 - 43. 10.1016/j.imlet.2008.11.001.

Hadjur, S; Williams, LM; Ryan, NK; Cobb, BS; Sexton, T; Fraser, P; Fisher, AG; (2009) Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. NATURE , 460 (7253) 410 - U130. 10.1038/nature08079.

Hall, JRAS; SC, ; (2009) Management of Glioblastoma Multiforme in HIV patients: a case series and review of published studies. Clinical Oncology

Hamer, M; O'Donnell, K; Steptoe, A; Lahiri, A; (2009) Neuroendocrine function and sub-clinical atherosclerosis in healthy adults. In: (Proceedings) 22nd Congress of the European-College-of-Neuropsychopharmacology. (pp. S198-S198). ELSEVIER SCIENCE BV

Hancock, BW; Qian, W; Linch, D; Delchier, J-C; Smith, P; Jakupovic, I; Burton, C; ... Zucca, E; + view all (2009) Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. BRITISH JOURNAL OF HAEMATOLOGY , 144 (3) pp. 367-375. 10.1111/j.1365-2141.2008.07486.x.

Hanna, SA; Whittingham-Jones, P; Sewell, MD; Pollock, RC; Skinner, JA; Saifuddin, A; Flanagan, A; ... Briggs, TWR; + view all (2009) Outcome of intralesional curettage for low-grade chondrosarcoma of long bones. EJSO , 35 (12) pp. 1343-1347. 10.1016/j.ejso.2009.06.001.

Harland, SJ; Welch, R; Huddart, R; Stenning, S; Pollock, P; Gabe, R; (2009) On the necessity for postchemotherapy surgery for residual abdominal masses in metastatic nonseminomatous germ cell tumors (NSGCT) of testis. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Harten, SK; Shukla, D; Barod, R; Hergovich, A; Balda, MS; Matter, K; Esteban, MA; (2009) Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin. MOL BIOL CELL , 20 (3) 1089 - 1101. 10.1091/mbc.E08-06-0566.

Harten, SK; Shukla, D; Barod, R; Hergovich, A; Balda, MS; Matter, K; Esteban, MA; (2009) Regulation of renal epithelial tight junctions by the von hippel-lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin. Molecular Biology of the Cell , 20 (3) pp. 1089-1101. 10.1091/mbc.E08-06-0566.

Hatton, C; Peniket, A; Tusold, A; Collins, G; Joyner, M; Lee, R; Mouncey, P; (2009) Single arm phase II open label study of thalidomide in patients with refractory or relapsed diffuse large B cell lymphoma. In: (Proceedings) 49th Annual Scientific Meeting/British Society for Haematology, Brighton.. (pp. 13-). British Journal of Haematology

Hatton, CSR; Peniket, A; Tusold, A; Collins, GP; Joyner, M; Lee, R; Mouncey, P; ... Lee, S-M; + view all (2009) Single arm phase II open label study of thalidomide in patients with refractory or relapsed diffuse large B cell lymphoma. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 13). WILEY-BLACKWELL PUBLISHING, INC

Henriquez, N; Jacques, TS; Swales, A; Brandner, S; (2009) Stem cells, progenitor cells and brain tumours: how related are they? In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 4 - 4). BLACKWELL PUBLISHING

Hergovich, A; Hemmings, BA; (2009) Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. BIOFACTORS , 35 (4) 338 - 345. 10.1002/biof.47.

Hergovich, A; Kohler, RS; Schmitz, D; Vichalkovski, A; Cornils, H; Hemmings, BA; (2009) The MST1 and hMOB1 Tumor Suppressors Control Human Centrosome Duplication by Regulating NDR Kinase Phosphorylation. CURR BIOL , 19 (20) 1692 - 1702. 10.1016/j.cub.2009.09.020.

Hewish, M; Miller, R; Forster, MD; Smith, IE; (2009) Severe synergistic toxicity from docetaxel in a patient treated concurrently with protease inhibitors as part of HIV-exposure prophylaxis: a case report. Journal of Medical Case Reports , 3 8866-.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, DW; Sayala, HA; Moreton, P; Oscier, D; ... Pocock, C; + view all (2009) An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL). In: BLOOD. (pp. 1331 - 1332). AMER SOC HEMATOLOGY

Hochhauser, D; Meyer, T; Spanswick, VJ; Wu, J; Clingen, PH; Loadman, P; Cobb, M; ... Jodrell, D; + view all (2009) Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (6) 2140 - 2147. 10.1158/1078-0432.CCR-08-1315.

Hochhauser, D; Meyer T, L; P, S; V J, C; M, B; R H, W; J, C; ... D, ; + view all (2009) Phase I study of the DNA minor groove binding pyrrolobenzodiazepine dimer (SJG 136) administered every 21 days in patients with advanced solid tumours. Clinical Cancer Research , 15 (6) pp. 2140-2147.

Holdsworth, R; Hurley, CK; Marsh, SGE; Lau, M; Noreen, HJ; Kempenich, JH; Setterholm, M; (2009) The HLA dictionary 2008: a summary of HLA-A, -B, -C,-DRB1/3/4/5, and-DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. TISSUE ANTIGENS , 73 (2) pp. 95-170. 10.1111/j.1399-0039.2008.01183.x.

Holmes, AM; Reed, MC; Baker, RJ; Jeevaratnam, P; Mehta, AB; Hughes, DA; (2009) Changes in left ventricular posterior wall thickness after treatment with enzyme replacement therapy and effect upon the Mainz Severity Score Index in patients with Fabry disease. In: (pp. S140-S140). DUSTRI-VERLAG DR KARL FEISTLE

Holmes, MV; Mehta, A; Morgan, MY; (2009) Hemiparesis in a 36 year old man. BMJ (Online) , 338 (7691) 419-. 10.1136/bmj.b90.

Holroyd, A; Townsend, W; Naik, P; Mackinnon, S; Howell, D; Goldstone, A; Linch, D; ... Morris, E; + view all (2009) Favourable outcome for allogeneic haematopoietic transplant recipients requiring intensive therapy unit admission with improved survival following reduced intensity conditioning. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 42 - 42). WILEY-BLACKWELL PUBLISHING, INC

Holroyd, A; Townsend, W; Naik, P; Mackinnon, S; Howell, D; Goldstone, A; Linch, D; ... Morris, E; + view all (2009) Favourable outcome for haematopoietic transplant recipients requiring intensive therapy unit admission: a 10-year single-centre experience. In: BONE MARROW TRANSPLANTATION. (pp. S23 - S23). NATURE PUBLISHING GROUP

Hoskin, PJ; Lowry, L; Horwich, A; Jack, A; Mead, B; Hancock, BW; Smith, P; ... Johnson, PWM; + view all (2009) Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. In: (Proceedings) 50th Annual Meeting of the American-Society-of-Hematology. (pp. pp. 5390-5396). AMER SOC CLINICAL ONCOLOGY

Hough, R; Cooper, N; Veys, P; (2009) Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available? BRITISH JOURNAL OF HAEMATOLOGY , 147 (5) pp. 593-613. 10.1111/j.1365-2141.2009.07841.x.

Howard, PW; Chen, Z; Gregson, SJ; Masterson, L; Tiberghien, AC; Cooper, N; Fang, M; ... Thurston, DE; + view all (2009) Synthesis of a novel C2/C2?-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction rate. Biorganic and Medicinal Chemistry Letters , 19 (22) pp. 6463-6466. 10.1016/j.bmcl.2009.09.012.

Howie, AJ; Brewer, DB; (2009) Optical properties of amyloid stained by Congo red: history and mechanisms. Micron , 40 (3) pp. 285-301. 10.1016/j.micron.2008.10.002.

Huang, Y; Moreau, A; Dupuis, J; Streubel, B; Petit, B; Le Gouill, S; Martin-Garcia, N; ... Gaulard, P; + view all (2009) Peripheral T-cell Lymphomas With a Follicular Growth Pattern are Derived From Follicular Helper T Cells (T(FH)) and may Show Overlapping Features With Angioimmunoblastic T-cell Lymphomas. AMERICAN JOURNAL OF SURGICAL PATHOLOGY , 33 (5) pp. 682-690.

Hubacek, P; Virgili, A; Ward, KN; Pohlreich, D; Keslova, P; Goldova, B; Markova, M; ... Cetkovsky, P; + view all (2009) HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis. BRIT J HAEMATOL , 145 (3) 394 - 398. 10.1111/j.1365-2141.2009.07622.x.

Hubbard, TJP; Aken, BL; Ayling, S; Ballester, B; Beal, K; Bragin, E; Brent, S; ... Flicek, P; + view all (2009) Ensembl 2009. NUCLEIC ACIDS RESEARCH , 37 D690-D697. 10.1093/nar/gkn828. Gold open access

Huggett, JF; Taylor, MS; Kocjan, G; (2009) Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients (vol 63, pg 154, 2008). THORAX , 64 (7) 643 - 643.

Hughes, C; Mcewan, JR; Longair, I; Hughes, S; Cohen, H; Machin, S; Scully, M; (2009) Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13. J THROMB HAEMOST , 7 (4) 529 - 536. 10.1111/j.1538-7836.2009.03285.x.

Hughes, D; (2009) The Management of Gaucher Disease as a Chronic Disorder. In: CLINICAL THERAPEUTICS. (pp. S182 - S182). ELSEVIER

Hughes, DA; (2009) Enzyme, substrate, and myeloma in Gaucher Disease. AM J HEMATOL , 84 (4) 199 - 201. 10.1002/ajh.21375.

Hughes, DA; Deegan, PB; Barba Romero, M-A; Giugliani, R; (2009) RESPONSES OF FEMALES WITH FABRY DISEASE TO ERT: COMPARISON WITH MALES, USING DATA FROM FOS - THE FABRY OUTCOME SURVEY. In: (Proceedings) 11th International Conference of Inborn Errors of Metabolism. (pp. p. 81). ACADEMIC PRESS INC ELSEVIER SCIENCE

Hughes, DA; Malmenas, MB; (2009) A PREDICTIVE SEVERITY SCORE FOR ANDERSON-FABRY DISEASE. In: (Proceedings) 11th International Conference of Inborn Errors of Metabolism. (pp. pp. 69-70). ACADEMIC PRESS INC ELSEVIER SCIENCE

Hussain, K; Padidela, R; Kapoor, RR; James, C; Banerjee, K; Harper, J; Wilson, LC; (2009) Diabetes mellitus, exocrine pancreatic deficiency, hypertrichosis, hyperpigmentation, and chronic inflammation: confirmation of a syndrome. PEDIATR DIABETES , 10 (3) 193 - 197. 10.1111/j.1399-5448.2008.00470.x.

I

Iatan, I; Bailey, D; Hafiane, A; Zanesi, N; Taccioli, C; Abu Odeh, M; Pajukanta, P; ... Genest, J; + view all (2009) Deficiency of the WW Domain-Containing Oxidoreductase (WWOX) Impairs the HDL Biogenesis Pathway. In: CIRCULATION. (pp. S476 - S477). LIPPINCOTT WILLIAMS & WILKINS

Isgro, G; Colvaruso, V; Manousou, P; Luong, TV; Andreana, L; Patch, DW; Davies, N; ... Burroughs, AK; + view all (2009) CORRELATION OF ISHAK STAGE,TRANSIENT ELASTOGRAPHY,HVPG AND COLLAGEN PROPORTIONATE AREA IN HCV TRANSPLANTED PATIENTS. In: HEPATOLOGY. (pp. 481A - 482A). JOHN WILEY & SONS INC

J

James, C; Kapoor, RR; Ismail, D; Hussain, K; (2009) The genetic basis of congenital hyperinsulinism. J MED GENET , 46 (5) 289 - 299. 10.1136/jmg.2008.064337.

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; Cunningham, D; ... Ledermann, J; + view all (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). In: (Proceedings) 45th Annual Meeting of the American-Society-of-Clinical-Oncology. AMER SOC CLINICAL ONCOLOGY

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; Cunningham, D; ... National Cancer Research Institute (NCRI) ACT II Trial Managemen, ; + view all (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol , 27 (18_suppl) LBA4009-.

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; Cunningham, D; ... National Cancer Research Institute (NCRI) ACT II Trial Managemen, ; + view all (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol , 27 (15_suppl) LBA4009-.

Janczar, S; Graham, JS; Paige, AJW; Gabra, H; (2009) Targeting locoregional peritoneal dissemination in ovarian cancer. Expert Review of Obstetrics & Gynecology , 4 (2) pp. 133-147. 10.1586/17474108.4.2.133.

Jenner, RG; Townsend, MJ; Jackson, I; Sun, KM; Bouwman, RD; Young, RA; Glimcher, LH; (2009) The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. P NATL ACAD SCI USA , 106 (42) 17876 - 17881. 10.1073/pnas.0909357106. Gold open access

Jennings, B; Harvey, R; Ish-Horowicz, D; (2009) Regulation of transcriptional elongation by spt5 during drosophila development. In: MECHANISMS OF DEVELOPMENT. (pp. S114 - S114). ELSEVIER SCIENCE BV

Joly, P; Jennings, BH; Jayasinghe, SN; (2009) Development and fertility studies on post-bio-electrosprayed Drosophila melanogaster embryos. BIOMICROFLUIDICS , 3 (4) , Article 044107. 10.1063/1.3267044.

K

Kalambokis, G; Manousou, P; Samonakis, D; Grillo, F; Dhillon, AP; Patch, D; O'Beirne, J; ... Burroughs, AK; + view all (2009) Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient. TRANSPL INT , 22 (2) 172 - 181. 10.1111/j.1432-2277.2008.00744.x.

Kapoor, RR; Flanagan, SE; James, C; Shield, J; Ellard, S; Hussain, K; (2009) Hyperinsulinaemic hypoglycaemia. ARCH DIS CHILD , 94 (6) 450 - 457. 10.1136/adc.2008.148171.

Kapoor, RR; James, C; Flanagan, SE; Ellard, S; Eaton, S; Hussain, K; (2009) 3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency and Hyperinsulinemic Hypoglycemia: Characterization of a Novel Mutation and Severe Dietary Protein Sensitivity. J CLIN ENDOCR METAB , 94 (7) 2221 - 2225. 10.1210/jc.2009-0423.

Kapoor, RR; James, C; Hussain, K; (2009) Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. NAT CLIN PRACT ENDOC , 5 (2) 101 - 112. 10.1038/ncpendmet1046.

Kapoor, RR; James, C; Hussain, K; (2009) Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nature Clinical Practice Endocrinology & Metabolism , 5 (3) p. 180. 10.1038/ncpendmet1096.

Kapoor, RR; James, C; Hussain, K; (2009) Hyperinsulinism in Developmental Syndromes. ENDOCRINE INVOLVEMENT IN DEVELOPMENTAL SYNDROMES , 14 95 - 113.

Kapur, A; Hall, RJ; Qureshi, AC; Malik, IS; Flather, M; Roughton, M; Beatt, KJ; (2009) COMPARISON OF BARE METAL STENTS VERSUS DRUG-ELUTING STENTS IN PATIENTS WITH MULTIVESSEL DISEASE AND DIABETES: RESULTS FROM A CARDIA TRIAL SUBSTUDY. In: HEART. (pp. A7 - A8). B M J PUBLISHING GROUP

Kaput, J; Cotton, RG; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; Al-Mulla, F; ... Yeom, YI; + view all (2009) Planning the human variome project: the Spain report. pp. 496-510.

Kaput, J; Cotton, RGH; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; Al-Mulla, F; ... Human Variome Project Planning, ; + view all (2009) Planning the Human Variome Project: The Spain Report. HUM MUTAT , 30 (4) 496 - 510. 10.1002/humu.20972.

Kashima, TG; Halai, DD; Tirabosco, R; Hing, S; Ye, H; Flanagan, AM; (2009) An Audit of Lipomatous Neoplasms: Correlation with MDM2 Amplification by Fluorescence In Situ Hybridisation. In: (Proceedings) 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 15A-15A). NATURE PUBLISHING GROUP

Kashima, TG; Halai, DD; Tirabosco, R; Hing, S; Ye, H; Flanagan, AM; (2009) An Audit of Lipomatous Neoplasms: Correlation with MDM2 Amplification by Fluorescence In Situ Hybridisation. In: (Proceedings) 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 15A-15A). NATURE PUBLISHING GROUP

Kayes, O; Loddo, M; Ambler, G; Stoeber, K; Williams, GH; Ralph, DJ; Minhas, S; (2009) DNA REPLICATION LICENSING FACTORS AND ANEUPLOIDY ARE LINKED TO TUMOUR CELL CYCLE STATES AND CLINICAL OUTCOME IN PENILE CARCINOMA. EUR UROL SUPPL , 8 (4) 368 - 368.

Kayes, O; Loddo, M; Ambler, G; Stoeber, K; Williams, GH; Ralph, DJ; Minhas, S; (2009) DNA replication licensing factors and aneuploidy are linked to tumour cell cycle states and clinical outcome in penile carcinoma. In: (Proceedings) 24th Annual EAU Congress. (pp. p. 368). Elsevier

Kayes, OJ; Loddo, M; Patel, N; Patel, P; Minhas, S; Ambler, G; Freeman, A; ... Williams, GH; + view all (2009) DNA Replication Licensing Factors and Aneuploidy Are Linked to Tumor Cell Cycle State and Clinical Outcome in Penile Carcinoma. CLIN CANCER RES , 15 (23) 7335 - 7344. 10.1158/1078-0432.CCR-09-0882.

Keenan, NG; Grasso, A; Locca, D; Varghese, A; Roughton, M; Gatehouse, PD; Firmin, DN; (2009) Comparison of 2D and multislab 3D magnetic resonance techniques for measuring carotid wall volumes (vol 28, pg 1476, 2008). J MAGN RESON IMAGING , 29 (6) 1493 - 1493. 10.1002/jmri.21771.

Keenan, NG; Locca, D; Varghese, A; Roughton, M; Gatehouse, PD; Hooper, J; Firmin, DN; (2009) Magnetic resonance of carotid artery ageing in healthy subjects. ATHEROSCLEROSIS , 205 (1) 168 - 173. 10.1016/j.atherosclerosis.2008.11.018.

Keenan, NG; Mason, JC; Maceira, A; Assomull, R; O'Hanlon, R; Chan, C; Roughton, M; ... Pennell, DJ; + view all (2009) Integrated Cardiac and Vascular Assessment in Takayasu Arteritis by Cardiovascular Magnetic Resonance. ARTHRITIS RHEUM , 60 (11) 3501 - 3509. 10.1002/art.24911.

Kelleher, MT; Fruhwirth, G; Patel, G; Ofo, E; Festy, F; Barber, PR; Ameer-Beg, SM; ... Ng, T; + view all (2009) The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Target Oncol , 4 (3) pp. 235-252. 10.1007/s11523-009-0116-y.

Ketchell, RI; Roughton, M; Agent, P; Gyi, K; Hodson, ME; (2009) Predicting survival in end-stage cystic fibrosis. RESP MED , 103 (10) 1441 - 1447. 10.1016/j.rmed.2009.04.025.

Khorashad, JS; Wagner, S; Greener, L; Marin, D; Reid, A; Milojkovic, D; Patel, H; ... Foroni, L; + view all (2009) The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 94 (6) pp. 861-864. 10.3324/haematol.2008.003715.

Kim, BS; Miyagawa, F; Cho, Y-H; Bennett, CL; Clausen, BE; Katz, SI; (2009) Keratinocytes Function as Accessory Cells for Presentation of Endogenous Antigen Expressed in the Epidermis. JOURNAL OF INVESTIGATIVE DERMATOLOGY , 129 (12) pp. 2805-2817. 10.1038/jid.2009.176.

Kimpfler, S; Sevko, A; Ring, S; Falk, C; Osen, W; Frank, K; Kato, M; ... Umansky, V; + view all (2009) Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. J Immunol , 183 (10) pp. 6330-6337. 10.4049/jimmunol.0900609.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; Wu, D; ... Pennell, DJ; + view all (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in Thalassemia Major. Circulation , 120 (20) pp. 1961-1968. 10.1161/CIRCULATIONAHA.109.874487.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; Wu, D; ... Pennell, DJ; + view all (2009) Cardiac T2*Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major. CIRCULATION , 120 (20) 1961 - U23. 10.1161/CIRCULATIONAHA.109.874487.

Kirwan, M; Beswick, R; Vulliamy, T; Nathwani, AC; Walne, AJ; Casimir, C; Dokal, I; (2009) Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. BRIT J HAEMATOL , 144 (5) 771 - 781. 10.1111/j.1365-2141.2008.07516.x.

Kishnani, PS; DiRocco, M; Kaplan, P; Mehta, A; Pastores, GM; Smith, SE; Puga, AC; (2009) A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. Molecular genetics and metabolism 10.1016/j.ymgme.2008.12.015.

Kitoh, A; Ono, M; Naoe, Y; Ohkura, N; Yamaguchi, T; Yaguchi, H; Kitabayashi, I; ... Sakaguchi, S; + view all (2009) Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity , 31 (4) pp. 609-620. 10.1016/j.immuni.2009.09.003.

Klanrit, P; Taebunpakul, P; Flinterman, MB; Odell, EW; Riaz, MA; Melino, G; Salomoni, P; ... Tavassoli, M; + view all (2009) PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers. ONCOGENE , 28 (39) 3499 - 3512. 10.1038/onc.2009.191.

Knight, A; Mackinnon, S; Lowdell, MW; (2009) CMV-Reactive Gamma/Delta T Cells Expanded From CMV Seronegative Normal Healthy Individuals Lyse CMV-Infected Targets - Potential Adoptive Immunotherapy for Recipients of Stem Cell Transplants From CMV Seronegative Donors. In: BLOOD. (pp. 880 - 880). AMER SOC HEMATOLOGY

Knight, SJL; Akha, ES; Timbs, A; Enver, T; Pettitt, AR; Taylor, J; Hatton, CS; (2009) Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 451). AMER SOC HEMATOLOGY

Kocjan, G; Chandra, A; Cross, P; Denton, K; Giles, T; Herbert, A; Smith, P; ... Wilson, P; + view all (2009) BSCC Code of Practice - fine needle aspiration cytology. CYTOPATHOLOGY , 20 (5) 283 - 296. 10.1111/j.1365-2303.2009.00709.x.

Kocjan, G; Ramsay, A; Beale, T; O'Flynn, P; (2009) Head and neck cancer in the UK: what is expected of cytopathology? CYTOPATHOLOGY , 20 (2) 69 - 77. 10.1111/j.1365-2303.2009.00647.x.

Kok, K; Geering, B; Vanhaesebroeck, B; (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. TRENDS IN BIOCHEMICAL SCIENCES , 34 (3) pp. 115-127. 10.1016/j.tibs.2009.01.003.

Kok, K; Nock, GE; Verrall, EA; Mitchell, MP; Hommes, DW; Peppelenbosch, MP; Vanhaesebroeck, B; (2009) Regulation of p110δ PI 3-Kinase Gene Expression. PLoS One , 4 (4) , Article e5145. 10.1371/journal.pone.0005145. Green open access
file

Kolman, P; Pica, A; Carvou, N; Boyde, A; Cockcroft, S; Loesch, A; Pizzey, A; ... Unwin, RJ; + view all (2009) Insulin uptake across the luminal membrane of the rat proximal tubule in vivo and in vitro. AM J PHYSIOL-RENAL , 296 (5) F1227 - F1237. 10.1152/ajprenal.90351.2008.

Kranc, KR; Schepers, H; Rodrigues, NP; Bamforth, S; Villadsen, E; Ferry, H; Bouriez-Jones, T; ... Enver, T; + view all (2009) Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells. CELL STEM CELL , 5 (6) pp. 659-665. 10.1016/j.stem.2009.11.001.

Krishnamurthy, S; Shaw, BE; Byrne, J; Seedhouse, C; Mayor, N; Madrigal, JA; Russell, N; (2009) A caspase8 promoter polymorphism is associated with increased TRM and reduced survival following T-cell depleted unrelated donor transplantation using alemtuzumab. In: BONE MARROW TRANSPLANTATION. (pp. S79 - S80). NATURE PUBLISHING GROUP

Kristeleit, R; Calvert, H; Arkenau, H; Olmos, D; Adam, J; Plummer, ER; Lock, V; ... Judson, I; + view all (2009) A phase I study of AT9283, an aurora kinase inhibitor, in patients with refractory solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Kristeleit, R; Calvert, H; Arkenau, H; Olmos, D; Adam, J; Plummer, ER; Lock, V; ... Judson, I; + view all (2009) A phase I study of AT9283, an aurora kinase inhibitor, in patients with refractory solid tumors. J Clin Oncol , 27 (15_suppl) 2566-.

Kristeleit, R; O'Brien, M; (2009) Cardiotoxicity from cytotoxics in the 21st century. British Journal of Cardiology , 16 (2) pp. 60-62.

Kristeleit, R; Sarker, D; Forster, M; Lolkema, M; Olmos, D; Mazina, K; Dolezal, MV; ... de Bono, JS; + view all (2009) A Phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941. In: (Proceedings) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology. (pp. p. 121). PERGAMON-ELSEVIER SCIENCE LTD

Kristeleit, RS; Calvert, H; Arkenau, H; Olmos, D; Adam, J; Plummer, ER; Lock, V; ... Judson, I; + view all (2009) A phase I study of AT9283, an aurora kinase inhibitor, in patients with refractory solid tumors. Journal of Clinical Oncology , 27 (15S)

Kulkarni, AA; Kingsbury, SR; Tudzarova, S; Hong, HK; Loddo, M; Rashid, M; Rodriguez-Acebes, S; ... Williams, GH; + view all (2009) Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma. CLIN CANCER RES , 15 (7) 2417 - 2425. 10.1158/1078-0432.CCR-08-1276.

Kummar, S; Doroshow, JH; Tomaszewski, JE; Calvert, AH; Lobbezoo, M; Giaccone, G; Task Force MDICT, ; (2009) Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies. EUR J CANCER , 45 (5) 741 - 746. 10.1016/j.ejca.2008.10.024.

Kwiatkowski, JL; Kim, HY; Thompson, AA; Quinn, CT; Mueller, BU; Odame, I; Giardina, PJ; ... Neufeld, EJ; + view all (2009) Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort. In: BLOOD. (pp. 1555 - 1556). AMER SOC HEMATOLOGY

Kyriakou, C; Canals, C; Finke, J; Kobbe, G; Harousseau, J-L; Kolb, H-J; Novitzky, N; ... Schmitz, N; + view all (2009) Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol , 27 (24) pp. 3951-3958. 10.1200/JCO.2008.20.4628.

L

Lacombe, T; Garcia-Gomez, JJ; de la Cruz, J; Roser, D; Hurt, E; Linder, P; Kressler, D; (2009) Linear ubiquitin fusion to Rps31 and its subsequent cleavage are required for the efficient production and functional integrity of 40S ribosomal subunits. MOLECULAR MICROBIOLOGY , 72 (1) pp. 69-84. 10.1111/j.1365-2958.2009.06622.x.

Lajiness, J; Sielaff, A; MacKay, H; Brown, T; Kluza, J; Nguyen, B; Wilson, WD; ... Hartley, JA; + view all (2009) Polyamide Curvature and DNA Sequence Selective Recognition: Use of 4-Aminobenzamide to Adjust Curvature. MED CHEM , 5 (3) 216 - 226.

Lambert, J; Linch, DC; Gale, RE; (2009) MULTIPLE JAK2 V617F MUTATIONS ARE PRESENT IN MOST PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA: A NEW DISEASE PARADIGM. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 421 - 421). FERRATA STORTI FOUNDATION Gold open access

Lambert, JR; Everington, T; Linch, DC; Gale, RE; (2009) In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm. BLOOD , 114 (14) 3018 - 3023. 10.1182/blood-2009-03-209916.

Lambert, JR; Gale, RE; Linch, DC; (2009) The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia. BRIT J HAEMATOL , 145 (1) 128 - 130. 10.1111/j.1365-2141.2009.07597.x.

Larkin, JMG; Kipps, ELS; Powell, CJ; Swanton, C; (2009) Systemic therapy for advanced renal cell carcinoma. Ther Adv Med Oncol , 1 (1) pp. 15-27. 10.1177/1758834009338430.

Lau-Walker, MO; Cowie, MR; Roughton, M; (2009) Coronary heart disease patients' perception of their symptoms and sense of control are associated with their quality of life three years following hospital discharge. J CLIN NURS , 18 (1) 63 - 71. 10.1111/j.1365-2702.2008.02386.x.

Lawrenson, K; Benjamin, E; Turmaine, M; Jacobs, I; Gayther, S; Dafou, D; (2009) In vitro three-dimensional modelling of human ovarian surface epithelial cells. CELL PROLIFERAT , 42 (3) 385 - 393. 10.1111/j.1365-2184.2009.00604.x.

Lawrie, AS; Albanyan, A; Cardigan, RA; Mackie, IJ; Harrison, P; (2009) Microparticle sizing by dynamic light scattering in fresh-frozen plasma. VOX SANG , 96 (3) 206 - 212. 10.1111/j.1423-0410.2008.01151.x.

Leclerc, X; Danos, O; Scherman, D; Kichler, A; (2009) A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair. BMC Biotechnol , 9 35-. 10.1186/1472-6750-9-35.

Ledermann, JA; Rustin, GJ; Hackshaw, A; Kaye, SB; Jayson, G; Gabra, H; James, LE; ... Temple, G; + view all (2009) A randomized phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 following treatment of relapsed ovarian cancer (OC). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Ledermann, JA; Rustin, GJ; Hackshaw, A; Kaye, SB; Jayson, G; Gabra, H; James, LE; ... Temple, G; + view all (2009) A randomized phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 following treatment of relapsed ovarian cancer (OC). J Clin Oncol , 27 (15_suppl) 5501-.

Ledermann, JA; Stebbing, J; (2009) Positioning pemetrexed in the treatment of ovarian cancer. EUR J CANCER , 45 (8) 1330 - 1332. 10.1016/j.ejca.2009.02.006.

Lee, AJX; Kolesnick, R; Swanton, C; (2009) RNAi-mediated functional analysis of pathways influencing cancer cell drug resistance. EXPERT REVIEWS IN MOLECULAR MEDICINE , 11 (ARTN e15) 10.1017/S1462399409001070.

Lee, CA; Chi, C; Shiltagh, N; Pollard, D; Griffioen, A; Dunn, N; Kadir, RA; (2009) Review of a multidisciplinary clinic for women with inherited bleeding disorders. HAEMOPHILIA , 15 (1) 359 - 360. 10.1111/j.1365-2516.2008.01824.x.

Lee, SM; Hackshaw, A; (2009) Correspondence. Response: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomised, double-blind, placebo-controlled trial. Journal of the National Cancer Institute

Lee, SM; James, LE; Qian, W; Spiro, S; Eisen, T; Gower, NH; Ferry, DR; ... Rudd, RM; + view all (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. THORAX , 64 (1) pp. 75-80. 10.1136/thx.2007.093872.

Lee, SM; Rudd, R; Woll, PJ; Ottensmeier, C; Gilligan, D; Price, A; Spiro, S; ... Hackshaw, A; + view all (2009) Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer. J Clin Oncol , 27 (31) pp. 5248-5254. 10.1200/JCO.2009.21.9733.

Lee, SM; Rudd, R; Woll, PJ; Ottensmeier, C; Gilligan, D; Price, A; Spiro, S; ... Hackshaw, A; + view all (2009) Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and carboplatin in advanced non-small-cell lung cancer. Journal of Clinical Oncology , 27 (31) pp. 5248-5254. 10.1200/JCO.2009.21.9733.

Lee, SM; Woll, PJ; Rudd, R; Ferry, D; O'Brien, M; Middleton, G; Spiro, S; ... Hackshaw, A; + view all (2009) Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst , 101 (15) pp. 1049-1057. 10.1093/jnci/djp200. Green open access

Leedham, SJ; Graham, TA; Oukrif, D; McDonald, SAC; Rodriguez-Justo, M; Harrison, RF; Shepherd, NA; ... Wright, NA; + view all (2009) Clonality, Founder Mutations, and Field Cancerization in Human Ulcerative Colitis-Associated Neoplasia. GASTROENTEROLOGY , 136 (2) 542 - 550. 10.1053/j.gastro.2008.10.086.

Leitner, S; Sweeney, K; Oberg, D; Davies, D; Miranda, E; Lemoine, NR; Hallden, G; (2009) Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo. Clinical Cancer Research , 15 (5) pp. 1730-1740. 10.1158/1078-0432.CCR-08-2008.

Lhériteau, E; Libeau, L; Stieger, K; Deschamps, J-Y; Mendes-Madeira, A; Provost, N; Lemoine, F; ... Rolling, F; + view all (2009) The RPGRIP1-deficient dog, a promising canine model for gene therapy. Mol Vis , 15 pp. 349-361.

Li, W; Ferguson, BJ; Khaled, WT; Tevendale, M; Stingl, J; Poli, V; Rich, T; ... Watson, CJ; + view all (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. P NATL ACAD SCI USA , 106 (12) 4725 - 4730. 10.1073/pnas.0807640106.

Liu, D; Zhang, T; Marshall, AJ; Okkenhaug, K; Vanhaesebroeck, B; Uzonna, JE; (2009) The p110 delta Isoform of Phosphatidylinositol 3-Kinase Controls Susceptibility to Leishmania major by Regulating Expansion and Tissue Homing of Regulatory T Cells. JOURNAL OF IMMUNOLOGY , 183 (3) pp. 1921-1933. 10.4049/jimmunol.0901099.

Liu, J; Lu, X; Drummond, C; Hutton, C; Jackson, J; Bennaceur, K; Newell, D; ... Lunec, J; + view all (2009) Mechanisms of cellular resistance to the growth inhibitory and cytotoxic effects of MDM2-p53 binding antagonists. In: AMER ASSOC CANCER RESEARCH

Liu, ML; Liu, MJ; Shen, YF; Ryu, H; Kim, HJ; Klupsch, K; Downward, J; (2009) Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-beta. J CELL SCI , 122 (11) 1917 - 1926. 10.1242/jcs.042226.

Loddo, M; Kingsbur, SR; Rashid, M; Proctor, I; Holt, C; Young, J; El Sheikh, S; ... Williams, GH; + view all (2009) Cell cycle phase progression analysis identifies unique replication phenotypes of major prognostic and predictive significance in cancer. In: CANCER RESEARCH. (pp. 320S - 320S). AMER ASSOC CANCER RESEARCH

Loddo, M; Kingsbury, SR; Rashid, M; Proctor, I; Holt, C; Young, J; El-Sheikh, S; ... Williams, GH; + view all (2009) Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. BRIT J CANCER , 100 (6) 959 - 970. 10.1038/sj.bjc.6604924.

Lolkema, MP; Harrington, K; Evans, J; Arkenau, HT; Roxburgh, P; Morrison, R; Roulstone, V; ... de Bono, J; + view all (2009) A phase-I study of the combination of intravenous reovirus (REOLYSIN (R)) and gemcitabine in patients with advanced cancer. In: (Proceedings) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology. (pp. p. 131). PERGAMON-ELSEVIER SCIENCE LTD

Loong, SLE; Hwang, JSG; Li, HH; Wee, JTS; Yap, SP; Chua, MLK; Fong, KW; (2009) Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01). RADIAT ONCOL , 4 , Article 23. 10.1186/1748-717X-4-23.

Lopez, MN; Pereda, C; Segal, G; Munoz, L; Aguilera, R; Gonzalez, FE; Escobar, A; ... Salazar-Onfray, F; + view all (2009) Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor beta-Expressing T Cells. J CLIN ONCOL , 27 (6) 945 - 952. 10.1200/JCO.2008.18.0794.

Lorenz, A; Osman, F; Folkyte, V; Sofueva, S; Whitby, MC; (2009) Fbh1 Limits Rad51-Dependent Recombination at Blocked Replication Forks. MOL CELL BIOL , 29 (17) 4742 - 4756. 10.1128/MCB.00471-09.

Lowdell, MW; Morris, E; (2009) Recent advances in clinical cellular immunotherapy. In: Practical Transfusion Medicine: Third Edition. (pp. 462-468).

Lowe, HL; Sharma, SK; Bagshawe, KD; Chester, KA; (2009) Antibody directed enzyme prodrug therapy (ADEPT). In: Recombinant Antibodies for Immunotherapy. (pp. 336-349).

Lugli, E; Ferraresi, R; Roat, E; Troiano, L; Pinti, M; Nasi, M; Nemes, E; ... Cossarizza, A; + view all (2009) Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. LEUKEMIA RES , 33 (1) 140 - 150. 10.1016/j.leukres.2008.07.025.

M

Mackall, C; Fry, T; Gress, R; Peggs, K; Storek, J; Toubert, A; (2009) Background to hematopoietic cell transplantation, including post transplant immune recovery. BONE MARROW TRANSPL , 44 (8) 457 - 462. 10.1038/bmt.2009.255.

Mackenzie, GD; Dunn, JM; Selvasekar, CR; Mosse, CA; Thorpe, SM; Novelli, MR; Bown, SG; (2009) Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy. LASER MED SCI , 24 (5) 729 - 734. 10.1007/s10103-008-0630-7.

Mahendran, AO; Elvey, M; Howie, AJ; Dupont, P; Veitch, PS; (2009) Early Renal Transplant Protocol Biopsies Directly Influence Patient Management. In: (Proceedings) 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation. (pp. p. 213). WILEY-BLACKWELL PUBLISHING, INC

Mahendran, AO; Elvey, M; Mahendran, M; Howie, AJ; Dupont, P; Veitch, PS; (2009) EARLY RENAL TRANSPLANT PROTOCOL BIOPSIES DIRECTLY INFLUENCE PATIENT MANAGEMENT. TRANSPLANT INTERNATIONAL , 22 p. 16.

Mahendran, AO; Haroon, S; Dupont, PJ; Howie, A; Veitch, PS; (2009) AN INCREMENTAL INCREASE IN CHRONIC ALLOGRAFT DAMAGE DETECTED ON PROTOCOL BIOPSIES DURING THE FIRST YEAR POST-TRANSPLANTATION. TRANSPL INT , 22 260 - 260.

Majumder, B; Lowdell, M; Smith, C; Rakhit, RD; (2009) Differential expression of local versus systemic platelet-monocyte complexes in the circulation of patients with acute coronary syndrome. In: (pp. pp. 197-198). OXFORD UNIV PRESS

Makrogianneli, K; Carlin, LM; Keppler, MD; Matthews, DR; Ofo, E; Coolen, A; Ameer-Beg, SM; ... Ng, T; + view all (2009) Integrating receptor signal inputs that influence small Rho GTPase activation dynamics at the immunological synapse. Mol Cell Biol , 29 (11) pp. 2997-3006. 10.1128/MCB.01008-08.

Malladi, R; Sloane-Stanley, J; Gupta, R; Rodrigues, N; Wood, W; Enver, T; (2009) THE EFFECT OF THE TEL-TRKC ONCOGENE ON THE HAEMATO-ENDOTHELIAL DIFFERENTIATION FROM HUMAN EMBRYONIC STEM CELLS. In: (Proceedings) 14th Annual Meeting of the European-Hematology-Association. (pp. p. 2). FERRATA STORTI FOUNDATION Gold open access

Mamopoulos, AM; Hughes, DA; Tuck, SM; Mehta, AB; (2009) Gaucher disease and pregnancy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY , 29 (3) pp. 240-242. 10.1080/01443610902754398.

Maniaci, V; Davidson, BR; Rolles, K; Dhillon, AP; Hackshaw, A; Begent, RH; Meyer, T; (2009) Fibrolamellar hepatocellular carcinoma - Prolonged survival with multimodality therapy. EJSO-EUR J SURG ONC , 35 (6) 617 - 621. 10.1016/j.ejso.2008.12.009.

Manousou, P; Arvaniti, V; Tsochatzis, E; Germani, G; Rolando, N; Pleguezuelo, M; Jones, K; ... Burroughs, AK; + view all (2009) RECURRENCE PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATION: THE EFFECT OF AZATHIOPRINE. In: JOURNAL OF HEPATOLOGY. (pp. S180 - S180). ELSEVIER SCIENCE BV

Manousou, P; Burroughs, AK; Isgro, G; Calvaruso, V; Luong, TV; Tsochatzis, E; Kalambokis, G; ... Dhillon, AP; + view all (2009) COMPUTER-ASSISTED IMAGE ANALYSIS OF LIVER COLLAGEN AT ONE YEAR BIOPSY CAN PREDICT CLINICAL OUTCOME IN HCV POST LT PATIENTS. In: HEPATOLOGY. (pp. 302A - 303A). JOHN WILEY & SONS INC

Manousou, P; Samonakis, D; Cholongitas, E; Patch, D; O'Beirne, J; Dhillon, AP; Rolles, K; ... Burroughs, AK; + view all (2009) Outcome of Recurrent Hepatitis C Virus After Liver Transplantation in a Randomized Trial of Tacrolimus Monotherapy Versus Triple Therapy. LIVER TRANSPLANT , 15 (12) 1783 - 1791. 10.1002/lt.21907.

Mansour, MR; (2009) Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma. EXPERT REVIEW OF HEMATOLOGY , 2 (2) pp. 133-136. 10.1586/EHM.09.3.

Mansour, MR; Sulis, ML; Duke, V; Foroni, L; Jenkinson, S; Koo, K; Allen, CG; ... Linch, DC; + view all (2009) Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol. J CLIN ONCOL , 27 (26) 4352 - 4356. 10.1200/JCO.2009.22.0996.

Mantovani, J; Charrier, S; Eckenberg, R; Saurin, W; Danos, O; Perea, J; Galy, A; (2009) Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome. J Gene Med , 11 (8) pp. 645-654. 10.1002/jgm.1346.

Manzano, L; Babalis, DS; Roughton, M; Shibata, MC; Anker, SD; Ghio, S; Poole-Wilson, PA; (2009) Predictors of Clinical Outcomes in Elderly Patients With Chronic Heart Failure: Results From the SENIORS Sstudy. In: CIRCULATION. (pp. S534 - S534). LIPPINCOTT WILLIAMS & WILKINS

Marelli, L; Shusang, V; Buscombe, JR; Cholongitas, E; Stigliano, R; Davies, N; Tibballs, J; ... Burroughs, AK; + view all (2009) Transarterial Injection of I-131-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer. JOURNAL OF NUCLEAR MEDICINE , 50 (6) pp. 871-877. 10.2967/jnumed.108.060558.

Marina, N; Bielack, S; Whelan, J; Smeland, S; Krailo, M; Sydes, MR; Butterfass-Bahloul, T; ... Bernstein, M; + view all (2009) International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience. PEDIATRIC AND ADOLESCENT OSTEOSARCOMA , 152 339 - 353.

Marks, DI; Paietta, EM; Moorman, AV; Richards, SM; Buck, G; DeWald, G; Ferrando, A; ... Lazarus, HM; + view all (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). BLOOD , 114 (25) 5136 - 5145. 10.1182/blood-2009-08-231217.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update April 2009. TISSUE ANTIGENS , 74 (3) pp. 272-275. 10.1111/j.1399-0039.2009.01322.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update August 2008. TISSUE ANTIGENS , 73 (1) pp. 91-92. 10.1111/j.1399-0039.2008.01165.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update December 2008. TISSUE ANTIGENS , 73 (6) pp. 629-631. 10.1111/j.1399-0039.2009.01242.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update February 2009. TISSUE ANTIGENS , 74 (2) pp. 180-182. 10.1111/j.1399-0039.2009.01285.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update January 2009. TISSUE ANTIGENS , 74 (2) pp. 177-179. 10.1111/j.1399-0039.2009.01284.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update July 2008. TISSUE ANTIGENS , 73 (1) pp. 88-90. 10.1111/j.1399-0039.2008.01164.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update June 2009. TISSUE ANTIGENS , 74 (4) pp. 364-366. 10.1111/j.1399-0039.2009.01330.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update March 2009. TISSUE ANTIGENS , 74 (2) pp. 183-186. 10.1111/j.1399-0039.2009.01288.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update May 2009. TISSUE ANTIGENS , 74 (4) pp. 358-363. 10.1111/j.1399-0039.2009.01321.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update November 2008. TISSUE ANTIGENS , 73 (4) pp. 383-384. 10.1111/j.1399-0039.2009.01212.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update October 2008. TISSUE ANTIGENS , 73 (4) pp. 381-382. 10.1111/j.1399-0039.2009.01211.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update September 2008. TISSUE ANTIGENS , 73 (1) pp. 93-94. 10.1111/j.1399-0039.2008.01169.x.

Marthandan, N; Karp, DR; Amett, F; Waller, MJ; Guidry, P; Feolo, M; Marsh, SGE; (2009) HLA genetic association analysis using the sequence feature variant type approach. JOURNAL OF IMMUNOLOGY , 182

Martin-Berenjeno, I; Vanhaesebroeck, B; (2009) PI3K Regulatory Subunits Lose Control in Cancer. CANCER CELL , 16 (6) pp. 449-450. 10.1016/j.ccr.2009.11.017.

Martín Caballero, I; Hansen, J; Leaford, D; Pollard, S; Hendrich, BD; (2009) The methyl-CpG binding proteins Mecp2, Mbd2 and Kaiso are dispensable for mouse embryogenesis, but play a redundant function in neural differentiation. PLoS One , 4 (1) , Article e4315. 10.1371/journal.pone.0004315. Green open access
file

Masir, N; Campbell, LJ; Goff, LK; Jones, M; Marafioti, T; Cordell, J; Clear, AJ; ... Lee, AM; + view all (2009) BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations. BRITISH JOURNAL OF HAEMATOLOGY , 144 (5) pp. 716-725. 10.1111/j.1365-2141.2008.07528.x.

Mattar, CN; Dighe, NM; Waddington, SN; McIntosh, J; Biswas, A; Fisk, NM; Davidoff, AM; ... Chan, J; + view all (2009) Long-Term Transgene Expression in New-Born Cynomolgus Macaques Following Intra-Uterine Gene Transfer of Self-Complementary AAV. In: MOLECULAR THERAPY. (pp. S117 - S117). NATURE PUBLISHING GROUP

Mayor, N; Shaw, BE; Cooke, L; Marsh, S; Madrigal, JA; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor haematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S203 - S203). NATURE PUBLISHING GROUP

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) Predicting disease relapse using NOD2/CARD15 SNP5 and HLA-DPB1 matching status. INT J IMMUNOGENET , 36 (5) 317 - 318.

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor hematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: TISSUE ANTIGENS. (pp. 403 - 403). WILEY-BLACKWELL PUBLISHING, INC

McCabe, DJH; Starke, R; Harrison, P; Brown, MM; Sidhu, PS; Mackie, IJ; Machin, SJ; (2009) ADAMTS-13 (VON WILLEBRAND FACTOR-CLEAVING PROTEASE) ACTIVITY IN THE EARLY AND LATE PHASES AFTER TRANSIENT ISCHAEMIC ATTACK OR ISCHAEMIC STROKE. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 103 - 104). B M J PUBLISHING GROUP

McCabe, N; Cerone, MA; Ohishi, T; Seimiya, H; Lord, CJ; Ashworth, A; (2009) Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene , 28 (11) pp. 1465-1470. 10.1038/onc.2008.483.

McClelland, B; Cohen, H; McClelland, B; (2009) Risks of transfusion in the context of haemovigilance: SHOT - the UK haemovigilance system. In: ABC of transfusion medicine: british medical journal books. (pp. 83-88). Wiley-Blackwell

McClelland, SE; Burrell, RA; Swanton, C; (2009) Chromosomal instability A composite phenotype that influences sensitivity to chemotherapy. CELL CYCLE , 8 (20) pp. 3262-3266.

McCormack, M; Ledermann, J; Hall-Craggs, M; Symonds, P; Warwick, V; Fernando, I; Hackshaw, A; (2009) Phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. In: (Proceedings) ASCO. (pp. A5586-).

McCormack, M; Ledermann, JA; Hall-Craggs, MA; Symonds, RP; Warwick, V; Simonds, H; Fernando, I; (2009) A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

McCormack, M; Ledermann, JA; Hall-Craggs, MA; Symonds, RP; Warwick, V; Simonds, H; Fernando, I; (2009) A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. J Clin Oncol , 27 (15_suppl) 5586-.

McDonald, V; Laffan, M; Benjamin, S; Bevan, D; Machin, S; Scully, MA; (2009) Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. BRIT J HAEMATOL , 144 (3) 430 - 433. 10.1111/j.1365-2141.2008.07458.x.

McDonald, V; Leandro, M; (2009) Rituximab in non-haematological disorders of adults and its mode of action. BRIT J HAEMATOL , 146 (3) 233 - 246. 10.1111/j.1365-2141.2009.07718.x.

McDonald, V; Scully, M; Manns, K; Mackie, IJ; Machin, SJ; (2009) Serum rituximab levels in TTP: the effect of plasma exchange and correlation with response to treatment. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). WILEY-BLACKWELL PUBLISHING, INC

McGovern, UB; Francis, RE; Peck, B; Guest, SK; Wang, J; Myatt, SS; Krol, J; ... Lam, EW-F; + view all (2009) Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mol Cancer Ther , 8 (3) pp. 582-591. 10.1158/1535-7163.MCT-08-0805.

McGovern, UB; Stebbing, J; (2009) Receptor-based predictors of response in breast cancer. [Editorial comment]. Future Oncology , 5 (3) 283 - 286. 10.2217/fon.09.1. Green open access
file

Mednick, L; Yu, SL; Trachtenberg, F; Kleinert, DA; Giardina, PJ; Kwiatkowski, JL; Foote, D; ... Yamashita, R; + view all (2009) Symptoms of Anxiety and Depression Among Teens and Adults in the Thalassemia Longitudinal Cohort Study. In: BLOOD. (pp. 231 - 232). AMER SOC HEMATOLOGY

Mehta, A; (2009) Eighth International Symposium on Lysosomal Storage Diseases. International Journal of Clinical Pharmacology and Therapeutics , 47 (supp 1) S1-S3.

Mehta, A; (2009) Psychosocial aspects of Fabry disease and their impact on optimal disease management. Clinical Therapeutics , 31 s1-s2.

Mehta, A; Clarke, JTR; Giugliani, R; Elliott, P; Linhart, A; Beck, MS-PG; (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survery. Journal of Medical Genetics , 46 pp. 548-552. 10.1136/jmg.2008.065904.

Mehta, A; Hoffbrand, A; (2009) Haematology at a Glance. [Book]. (3rd ed.). Blackwell Wiley

Mehta, AB; (2009) Anderson – Fabry Disease : developments in diagnosis and therapy. International Journal of Clinical Pharmacology and Therapeutics , 47 (1) s66-s74.

Mehta, AB; (2009) Common hereditary lysosomal storage disorders. BMJ Point of Care

Meng, S; Arbit, T; Veeriah, S; Mellinghoff, IK; Fang, F; Vivanco, I; Rohle, D; (2009) 14-3-3 sigma and p21 synergize to determine DNA damage response following Chk2 inhibition. CELL CYCLE , 8 (14) pp. 2238-2246. 10.4161/cc.8.14.8998.

Meyer, T; (2009) Interventional Radiological Treatment of Liver Tumours. British Journal of Cancer , 100 p. 1975.

Meyer, T; Gaya, AM; Dancey, G; Stratford, MRL; Othman, S; Sharma, SK; Wellsted, D; ... Begent, RH; + view all (2009) A Phase I Trial of Radioimmunotherapy with I-131-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas. CLIN CANCER RES , 15 (13) 4484 - 4492. 10.1158/1078-0432.CCR-09-0035.

Meys, R; Fowles, F; Little, A; Marsh, SG; Asboe, D; Hawkins, DA; Gotch, FM; (2009) Immunogenetics of HIV associated HPV disease after HAART. In: (Proceedings) 69th Annual Meeting of the Society-of-Investigative-Dermatology. (pp. S82-S82). NATURE PUBLISHING GROUP

Michelagnoli, M; Kotecha, K; Anazado, A; Flanagan, A; Tirabosco, R; Briggs, T; Cannon, S; ... Whelan, J; + view all (2009) OUTLOOK FOR CHILDREN UNDER 13 YEARS WITH PRIMARY MALIGNANT BONE TUMOURS - THE LONDON SARCOMA SERVICE EXPERIENCE 1999-2009. PEDIATR BLOOD CANCER , 53 (5) 797 - 798.

Middleton, D; Gonzalez, F; Fernandez-Vina, M; Tiercy, J-M; Marsh, SGE; Aubrey, M; Bicalho, MG; ... Yang, KL; + view all (2009) A bioinformatics approach to ascertaining the rarity of HLA alleles. TISSUE ANTIGENS , 74 (6) pp. 480-485. 10.1111/j.1399-0039.2009.01361.x.

Miene, C; Klenow, S; Veeriah, S; Richling, E; Glei, M; (2009) Impact of apple polyphenols on GSTT2 gene expression, subsequent protection of DNA and modulation of proliferation using LT97 human colon adenoma cells. MOLECULAR NUTRITION & FOOD RESEARCH , 53 (10) pp. 1254-1262. 10.1002/mnfr.200800444.

Mikosch, P; Reed, M; Stettner, H; Baker, R; Mehta, AB; Hughes, DA; (2009) Patients with Gaucher disease living in England show a high prevalence of vitamin D insufficiency with correlation to osteodensitometry. MOLECULAR GENETICS AND METABOLISM , 96 (3) pp. 113-120. 10.1016/j.ymgme.2008.12.001.

Milhas, D; Lafont, E; Levade, T; Benoist, H; Segui, B; (2009) CASPASE-MEDIATED INHIBITION OF SPHINGOMYELIN SYNTHESIS IS INVOLVED IN FASL-TRIGGERED CELL DEATH. In: (Proceedings) 7th International Meeting of the Sphingolipid-Club. (pp. p. 366). SPRINGER

Miller, K; Ibrahim, M; Herriot, K; (2009) The UK NEQAS online auditing system for breast cancer predictive markers. VIRCHOWS ARCH , 455 75 - 75.

Mischerikow, N; Spedale, G; Altelaar, AFM; Timmers, HTM; Pijnappel, WWMP; Heck, AJR; (2009) In-depth profiling of post-translational modifications on the related transcription factor complexes TFIID and SAGA. J Proteome Res , 8 (11) pp. 5020-5030. 10.1021/pr900449e.

Mohamedbhai, SG; Lowry, L; Goldstone, AH; Linch, DC; Ardeshna, KM; (2009) Rituximab in combination with CODOX-M/IVAC: toxicity and efficacy in 17 adults with non-HIV related B-cell non-Hodgkin lymphomas with 495% proliferation index. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 15 - 16). WILEY-BLACKWELL PUBLISHING, INC

Moilanen, P; Korppi, M; Hovi, L; Chapgier, A; Feinberg, J; Kong, X-F;